var title_f7_0_7168="Distal clavicle fracture type II A";
var content_f7_0_7168=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Distal clavicle fracture type II A",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture depicts a type II A distal clavicle fracture. In type IIA injuries, both conoid and trapezoid ligaments are attached to the distal segment, whereas the proximal segment without ligamentous attachments becomes displaced.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rockwood CA Jr, Green DP, Bucholz RW, Heckman JD (Eds). Rockwood and Green's Fractures in Adults, 4th ed, Lippincott-Raven, Philadelphia 1996. Copyright &copy; 1996 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7168=[""].join("\n");
var outline_f7_0_7168=null;
var title_f7_0_7169="Chair stand exercise";
var content_f7_0_7169=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Strength exercise: Chair stand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This exercise, which strengthens your abdomen and thighs, will make it easier to get in and out of the car. If you have knee or back problems, talk with your doctor before trying this exercise.",
"    <ol>",
"     <li>",
"      Sit toward the front of a sturdy, armless chair with knees bent and feet flat on floor, shoulder-width apart.",
"     </li>",
"     <li>",
"      Lean back with your hands crossed over your chest. Keep your back and shoulders straight throughout exercise. Breathe in slowly.",
"     </li>",
"     <li>",
"      Breathe out and bring your upper body forward until sitting upright.",
"     </li>",
"     <li>",
"      Extend your arms so they are parallel to the floor and slowly stand up.",
"     </li>",
"     <li>",
"      Breathe in as you slowly sit down.",
"     </li>",
"     <li>",
"      Repeat 10 to 15 times.",
"     </li>",
"     <li>",
"      Rest; then repeat 10 to 15 more times.",
"     </li>",
"    </ol>",
"    People with back problems should start the exercise from the sitting upright position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Go4Life. National Institute on Aging at the National Institutes of Health. Available at: file://go4life.niapublications.org (Accessed December 2, 2011).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7169=[""].join("\n");
var outline_f7_0_7169=null;
var title_f7_0_7170="Symptoms of HIV infection";
var content_f7_0_7170=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Symptoms of HIV infection (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?7/0/7170/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7170/contributors\" id=\"au4340\">",
"       Paul E Sax, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?7/0/7170/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7170/contributors\" id=\"se136\">",
"       John G Bartlett, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?7/0/7170/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7170/contributors\" id=\"de8449\">",
"       Allyson Bloom, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?7/0/7170?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      OVERVIEW OF HIV SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     It is important to recognize symptoms of HIV as soon as possible since early diagnosis and treatment will prevent serious illness. Early treatment will also reduce your chances of transmitting the virus to others.",
"    </p>",
"    <p>",
"     This article discusses the early signs and symptoms of HIV and the groups that are at risk for becoming infected with HIV. A separate article discusses testing for HIV. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"      \"Patient information: Testing for HIV (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      WHO IS AT RISK FOR HIV?",
"     </span>",
"    </p>",
"    <p>",
"     HIV infection is usually acquired through sexual intercourse or exposure to infected blood or body fluids. This may occur:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       During sexual contact with an infected person, especially if you have unprotected vaginal or anal sex",
"      </li>",
"      <li>",
"       By sharing needles or syringes used by an infected person.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Transmission from a pregnant woman to her baby may occur during pregnancy, birth, or breastfeeding, although this is uncommon with the use of HIV medications during and after pregnancy.",
"    </p>",
"    <p>",
"     HIV infection is NOT spread by casual contact.",
"    </p>",
"    <p>",
"     Certain individuals may have an increased risk of HIV infection, including the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       People with a history of a sexually transmitted disease",
"      </li>",
"      <li>",
"       Sexual partners of people who are infected with HIV",
"      </li>",
"      <li>",
"       Victims of sexual assault (see",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?1/30/1509?source=see_link\">",
"        \"Patient information: Care after sexual assault (Beyond the Basics)\"",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Men and women who have unprotected sex with multiple partners",
"      </li>",
"      <li>",
"       Men and women who exchange sex for money or drugs or have sex partners who do",
"      </li>",
"      <li>",
"       Men who have sex with men",
"      </li>",
"      <li>",
"       Injection drug users who share needles or \"works\"",
"      </li>",
"      <li>",
"       Anyone who is accidentally stuck with a needle or sharp in a healthcare facility",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      HIV SYMPTOMS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4614778\">",
"     <span class=\"h2\">",
"      Symptoms of early HIV infection",
"     </span>",
"     &nbsp;&mdash;&nbsp;Early symptoms of HIV infection develop in 50 to 90 percent of people who are infected, usually beginning two to four weeks after exposure to HIV. The initial group of signs and symptoms is referred to as primary or acute HIV infection.",
"    </p>",
"    <p>",
"     Because the signs and symptoms of primary HIV may be similar to other common illnesses such as the flu, most people do not initially realize that they have HIV. However, HIV infection is highly contagious at this early stage because there are large amounts of the virus in the blood and other bodily fluids. Recognizing symptoms early, being tested for HIV, and starting HIV treatment as soon as possible can help to decrease the risk of transmitting HIV to another person.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h3\">",
"      Body-wide symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common body-wide signs and symptoms of primary HIV include fever (temperature above 100.4&ordm;F or 38&ordm;C), sore throat, headache, and muscle and joint pain. These flu-like symptoms last approximately two weeks.",
"    </p>",
"    <p>",
"     During the second week of the illness, most people also have painless swelling of certain lymph nodes, including those in the armpits and in the neck. Although the lymph nodes decrease in size after the first few weeks, swelling can linger.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h3\">",
"      Skin, mouth, genital symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;A characteristic feature of primary HIV infection is open sores or ulcers. These sores or ulcers can develop in the mouth, the esophagus (the tube that extends from the mouth to the stomach), the anus, or the penis. The ulcers are usually painful.",
"    </p>",
"    <p>",
"     Many people also develop a rash of the skin about two to three days after fever. The rash usually affects the face, neck, and upper chest or may be more widespread. The rash usually lasts approximately 5 to 8 days.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h3\">",
"      Digestive symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many people with primary HIV infection develop nausea and vomiting, diarrhea, lack of appetite, and weight loss.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Respiratory symptoms",
"     </span>",
"     &nbsp;&mdash;&nbsp;A dry cough is usually the only respiratory symptom associated with primary HIV infection.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4614817\">",
"     <span class=\"h2\">",
"      Symptoms of advanced HIV infection",
"     </span>",
"     &nbsp;&mdash;&nbsp;If HIV is not treated, the virus will cause progressive weakening of the immune system, a process which occurs at different rates in different people. Once significant damage to the immune system has occurred, which typically takes at least several years, patients with HIV can become infected with other organisms that usually don&rsquo;t cause illness in people with normal immunity. These &ldquo;opportunistic infections&rdquo; can cause serious disease in patients with advanced HIV infection. Depending on the opportunistic infection, symptoms may include shortness of breath, blurred vision, fevers, and weight loss.",
"    </p>",
"    <p>",
"     One of the most common opportunistic infections is yeast infection of the mouth or esophagus. Yeast infections are caused by Candida, a fungal organism that is normally found on the skin and in the mouth, intestinal tract, and vagina in healthy individuals. Certain yeast infections can occur in people without HIV, (eg, vaginal yeast infections) although people with HIV are at a higher risk for this and other types of opportunistic infections. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/53/2899?source=see_link\">",
"      \"Patient information: Vaginal yeast infection (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Candidiasis of the mouth, also known as thrush, causes cream-colored, slightly raised patches in the mouth, soreness, and easy bleeding.",
"      </li>",
"      <li>",
"       Candidiasis of the esophagus may cause difficulty swallowing.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     However, with diagnosis and treatment of HIV, the immune system can improve. Then the risk of opportunistic infections goes down. While the immune system is recovering, certain medications can help prevent any opportunistic infections from occurring in the first place. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/39/44658?source=see_link\">",
"      \"Patient information: Preventing opportunistic infections in HIV (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      TESTING FOR HIV",
"     </span>",
"    </p>",
"    <p>",
"     HIV testing is the only way to determine if you are infected with HIV. Most individuals who are at the highest risk for HIV have not been tested, usually because they do not realize that they are at risk. Others avoid testing because they are worried about the possibility of a positive test result.",
"    </p>",
"    <p>",
"     However, testing is encouraged because treatment for HIV is highly effective and learning about the infection can improve your chance of living longer and being healthier. Furthermore, knowing your HIV status and taking precautions can greatly reduce your risk of transmitting the virus to others. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"      \"Patient information: Testing for HIV (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22808?source=see_link\">",
"      \"Acute and early HIV infection: Treatment\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7376797\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7376804\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/25/21907?source=see_link\">",
"      Patient information: HIV/AIDS (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/31/18931?source=see_link\">",
"      Patient information: Blood or body fluid exposure (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/35/31282?source=see_link\">",
"      Patient information: Preventing HIV after unprotected sex or needle-sharing (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/13/10451?source=see_link\">",
"      Patient information: Tests to monitor HIV (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/57/1940?source=see_link\">",
"      Patient information: Screening for sexually transmitted diseases (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/44/4803?source=see_link\">",
"      Patient information: Urethritis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"./kaposis-sarcoma-the-basics?source=see_link\">",
"      Patient information: Kaposi&rsquo;s sarcoma (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7376862\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/60/1986?source=see_link\">",
"      Patient information: Testing for HIV (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/30/1509?source=see_link\">",
"      Patient information: Care after sexual assault (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/39/44658?source=see_link\">",
"      Patient information: Preventing opportunistic infections in HIV (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/53/2899?source=see_link\">",
"      Patient information: Vaginal yeast infection (Beyond the Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7376877\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/8/22665?source=see_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of Pneumocystis pneumonia in non-HIV-infected patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22808?source=see_link\">",
"      Acute and early HIV infection: Treatment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18151?source=see_link\">",
"      Acute and early HIV infection: Pathogenesis and epidemiology",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33450?source=see_link\">",
"      Primary prevention of opportunistic infections in HIV-infected patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/34/10793?source=see_link\">",
"      Serologic screening for HIV infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21320?source=see_link\">",
"      Techniques and interpretation of measurement of the CD4 cell count in HIV-infected patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/44/1737?source=see_link\">",
"      The adolescent with HIV infection",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/2/21546?source=see_link\">",
"      The global human immunodeficiency virus pandemic",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/2/13353?source=see_link\">",
"      The stages and natural history of HIV infection",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Centers for Disease Control and Prevention (CDC)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; Toll-free: (800) 311-3435",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/\">",
"      www.cdc.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       CDC (Centers for Disease Control and Prevention) National AIDS Hotline",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;English: (800) 342-2437",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;Spanish: (800) 344-7432",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       CDC National Prevention Information Network (NPIN)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 458-5231",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Allergy and Infectious Diseases (NIAID)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niaid.nih.gov/\">",
"      www.niaid.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <span class=\"nowrap\">",
"        HIV/AIDS",
"       </span>",
"       Treatment Information Service",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 448-0440",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.aidsinfo.nih.gov/\">",
"      www.aidsinfo.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       AIDS Clinical Trials Information Service (ACTIS)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 874-2572",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.actis.org/\">",
"      www.actis.org",
"     </a>",
"     )",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Patient Support",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are a number of online forums where patients can find information and support from other people with similar conditions.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       <a class=\"external\" href=\"file://about.com/\">",
"        About.com",
"       </a>",
"       <span class=\"nowrap\">",
"        HIV/AIDS",
"       </span>",
"       Forum",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://aids.about.com/forum\">",
"      file://aids.about.com/forum",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?7/0/7170/abstract/1-6\">",
"      1-6",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 15, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?7/0/7170?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7170/abstract/1\">",
"      Pilcher CD, Tien HC, Eron JJ Jr, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004; 189:1785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7170/abstract/2\">",
"      Walensky RP, Goldie SJ, Sax PE, et al. Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy. J Acquir Immune Defic Syndr 2002; 31:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7170/abstract/3\">",
"      Quinn TC. Acute primary HIV infection. JAMA 1997; 278:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7170/abstract/4\">",
"      Pao D, Fisher M, Hu&eacute; S, et al. Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 2005; 19:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7170/abstract/5\">",
"      Schacker T, Collier AC, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7170/abstract/6\">",
"      Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 Infection. N Engl J Med 2011; 364:1943.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f7_0_7170=[""].join("\n");
var outline_f7_0_7170=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           OVERVIEW OF HIV SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           WHO IS AT RISK FOR HIV?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           HIV SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           TESTING FOR HIV",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f7_0_7171="Cauda equina PI";
var content_f7_0_7171=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83945&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83945&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 490px\">",
"   <div class=\"ttl\">",
"    Cauda equina syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 470px; height: 687px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cauda equina is a bundle of nerves that spread out from the bottom of the spinal cord (see label). Cauda equina syndrome happens when some of the nerves in the cauda equina get squeezed or damaged.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7171=[""].join("\n");
var outline_f7_0_7171=null;
var title_f7_0_7172="Clinical manifestations of spontaneous bacterial peritonitis";
var content_f7_0_7172=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations of spontaneous bacterial peritonitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/0/7172/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7172/contributors\">",
"     Bruce A Runyon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/0/7172/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7172/contributors\">",
"     Keith D Lindor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/0/7172/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7172/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/0/7172/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous bacterial peritonitis (SBP) is defined as an ascitic fluid infection without an evident intra-abdominal surgically-treatable source; it primarily occurs in patients with advanced cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/1\">",
"     1",
"    </a>",
"    ]. The diagnosis is established by a positive ascitic fluid bacterial culture and an elevated ascitic fluid absolute polymorphonuclear leukocyte (PMN) count (&ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3).",
"    </span>",
"    An elevated ascitic fluid absolute polymorphonuclear leukocyte (PMN) count (&ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3)",
"    </span>",
"    is adequate to make a presumptive diagnosis of SBP and to start empiric therapy. Too often the paracentesis is performed after antibiotics are initiated",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inadequate culture technique is used. In these situations, culture is regularly negative. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12296?source=see_link\">",
"     \"Diagnosis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An important issue in differential diagnosis is distinguishing SBP from a surgically-treatable cause of secondary bacterial peritonitis (eg, due to a perforated viscus). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12296?source=see_link\">",
"     \"Diagnosis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations of SBP will be reviewed here. The treatment of this disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4121?source=see_link\">",
"     \"Treatment and prophylaxis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The signs and symptoms of spontaneous bacterial peritonitis (SBP) are subtle compared with those of patients who have surgical peritonitis in the absence of ascites. By separating the visceral from the parietal peritoneal surfaces, ascites prevents the development of a rigid abdomen [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Clinical setting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with SBP generally have advanced cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/1\">",
"     1",
"    </a>",
"    ]. The higher the MELD score, the higher the risk of SBP [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/3\">",
"     3",
"    </a>",
"    ]. Spontaneous infection of noncirrhotic ascites (eg, due to malignancy or heart failure) is unusual enough to be the subject of case reports or small series. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34197?source=see_link\">",
"     \"Pathogenesis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients almost always develop SBP in the setting of large-volume, clinically obvious ascites. We have only encountered two patients (out of more than 1000) who developed SBP in clinically undetectable ascites; both were children. SBP develops in preexisting ascites; it does not cause fluid to form.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Changes in presentation in recent years",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the 1960s and 1970s the index of suspicion of ascitic fluid infection was low and the threshold for performing a paracentesis was high. As a result, infection was detected at an advanced stage in which shock was common and mortality was high [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/4\">",
"     4",
"    </a>",
"    ]. SBP is currently detected much earlier. Patients with ascites undergo surveillance paracentesis upon admission to the hospital; this procedure is also performed in patients who develop any signs or symptoms of infection (",
"    <a class=\"graphic graphic_table graphicRef64189 \" href=\"UTD.htm?21/0/21515\">",
"     table 1",
"    </a>",
"    ). The net effect is that now approximately 13 percent of patients with SBP have no signs or symptoms of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/5\">",
"     5",
"    </a>",
"    ]. When symptoms do occur, the most common are fever, abdominal pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tenderness, and altered mental status (",
"    <a class=\"graphic graphic_table graphicRef71038 \" href=\"UTD.htm?17/61/18395\">",
"     table 2",
"    </a>",
"    ). The only features of SBP in some patients are leukocytosis, acidosis, or worsening renal function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever is clearly the most common manifestation of SBP. It is important to appreciate in this regard that patients with advanced cirrhosis are usually mildly hypothermic. Thus, a temperature of 37.8&ordm;C (100&ordm;F) or greater must be taken very seriously, similar to the situation in the patient with neutropenia. As a result, we give written instructions for patients to call our office if their temperature rises to this level. If the patient has a clear-cut viral syndrome, the problem may be handled over the telephone. Otherwise, evaluation in the clinic, urgent care, or emergency department is warranted. Paracentesis, urinalysis, complete blood count, and bacterial culture of ascitic fluid, urine, and blood are obtained. If the patient looks ill, hospitalization is required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12296?source=see_link\">",
"     \"Diagnosis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is frequently a very short window of opportunity in which to intervene to ensure a good outcome. If this opportunity is missed, shock ensues, followed rapidly by multisystem organ failure. Survival is unlikely in patients who develop shock prior to initiation of empiric antibiotics. One report estimated that survival decreased by approximately 8 percent for each hour of delay in starting antibiotics in patients with septic shock [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Abdominal pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse abdominal pain is the hallmark of peritonitis. However, the pain can be very subtle in SBP due to the presence of ascites. The pain is usually diffuse and continuous; it is different from the pain induced by stretching of the abdominal wall due to tense ascites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Altered mental status",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical sign of infection that is frequently overlooked in the patient with cirrhosis is a subtle change in mental status. This finding was present in 54 percent of patients in a 1990 series and 54 percent of those in a later large review [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/5,7\">",
"     5,7",
"    </a>",
"    ]. Both the infection itself and hepatic decompensation may contribute to this problem. Ammonia levels do not correlate well with mental status [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This alteration in mental status may be so subtle that it can only be detected by a spouse or a clinician who knows the patient well. The Reitan trail test is helpful in detecting subtle changes in mental status in the patient with cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/9\">",
"     9",
"    </a>",
"    ]. This is a connect-the-number test that is timed. Patients without hepatic encephalopathy should finish the test in a matter of seconds comparable to their age in years. In other words if a patient is 50 years old, he should be able to finish the test in &lt;50 seconds. If he cannot, he probably has hepatic encephalopathy. This test can be administered in the clinic or on the ward by a clinician, nurse, or assistant. It is much more helpful, cheaper, and more rapidly available than a plasma ammonia concentration. The key is having a copy of the test on hand and to keep an unused copy for photocopying. The test traditionally has two parts, but we only use part A since in our experience part B can be confusing and does not add important clinical information (",
"    <a class=\"graphic graphic_figure graphicRef83108 \" href=\"UTD.htm?0/32/527\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef83109 \" href=\"UTD.htm?36/49/37662\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Abdominal tenderness",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with abdominal pain, abdominal tenderness is a classic sign of peritonitis that can be subtle in SBP. These patients do not develop a rigid abdomen, although rebound may be present in advanced cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alteration in gut flora with overgrowth of one organism (usually Escherichia coli) has been documented in an animal model of cirrhosis and SBP [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7172/abstract/10\">",
"     10",
"    </a>",
"    ]. These animals regularly develop diarrhea as this occurs, followed by extraintestinal dissemination of the pathogen which may herald the onset of ascitic fluid infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34197?source=see_link\">",
"     \"Pathogenesis of spontaneous bacterial peritonitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Paralytic ileus, hypotension, hypothermia",
"    </span>",
"    &nbsp;&mdash;&nbsp;These more severe signs are indicative of advanced infection and a poor likelihood of survival. As noted above, it is important to detect infection and begin antibiotic treatment before this stage is reached.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laboratory abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally an infected patient with cirrhosis will have no clinical signs or symptoms, but will have subtle laboratory signs of infection. These include leukocytosis, metabolic acidosis, and azotemia. The otherwise unexplained presence of one or more of these abnormalities should prompt abdominal paracentesis in a patient with cirrhosis and ascites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18387463\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous bacterial peritonitis (SBP) is defined as an ascitic fluid infection without an evident intra-abdominal surgically treatable source; it primarily occurs in patients with advanced cirrhosis. The diagnosis is established by a positive ascitic fluid bacterial culture and an elevated ascitic fluid absolute polymorphonuclear leukocyte (PMN) count (&ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3).",
"    </span>",
"    An elevated ascitic fluid absolute polymorphonuclear leukocyte (PMN) count (&ge;250",
"    <span class=\"nowrap\">",
"     cells/mm3)",
"    </span>",
"    is adequate to make a presumptive diagnosis of SBP and to start empiric therapy.",
"   </p>",
"   <p>",
"    Patients with SBP generally have advanced cirrhosis; the higher the MELD score, the higher the risk of SBP. Patients almost always develop SBP in the setting of large-volume, clinically obvious ascites.",
"   </p>",
"   <p>",
"    The most common features of SBP are fever, abdominal pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tenderness, and altered mental status (",
"    <a class=\"graphic graphic_table graphicRef71038 \" href=\"UTD.htm?17/61/18395\">",
"     table 2",
"    </a>",
"    ). The only features of SBP in some patients are leukocytosis, acidosis, or worsening renal function. However, approximately 13 percent of patients have no signs or symptoms of infection. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Changes in presentation in recent years'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H117452326\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the death of Marshall M. Kaplan, MD, who passed away in September 2012. UpToDate wishes to acknowledge Dr. Kaplan's many contributions to our program, in particular, his work on this topic as our Section Editor for Alcoholic and Metabolic Liver Disease.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7172/abstract/1\">",
"      Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7172/abstract/2\">",
"      Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 1990; 98:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7172/abstract/3\">",
"      Obstein KL, Campbell MS, Reddy KR, Yang YX. Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol 2007; 102:2732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7172/abstract/4\">",
"      Hoefs JC, Runyon BA. Spontaneous bacterial peritonitis. Dis Mon 1985; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7172/abstract/5\">",
"      Runyon BA. Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology 1990; 12:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7172/abstract/6\">",
"      Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589.",
"     </a>",
"    </li>",
"    <li>",
"     McHutchison JG, Runyon BA. Spontaneous bacterial peritonitis. In: Gastrointestinal and Hepatic Infections, Surawicz CM, Owen RL (Eds), WB Saunders, Philadelphia 1994. p.455.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7172/abstract/8\">",
"      EICHLER M, BESSMAN SP. A double-blind study of the effect of ammonium infusion on psychological functioning in cirrhotic patients. J Nerv Ment Dis 1962; 134:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7172/abstract/9\">",
"      Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977; 22:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7172/abstract/10\">",
"      Guarner C, Runyon BA, Young S, et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26:1372.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1247 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.247-661AF214C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7172=[""].join("\n");
var outline_f7_0_7172=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18387463\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Clinical setting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Changes in presentation in recent years",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Altered mental status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Abdominal tenderness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Paralytic ileus, hypotension, hypothermia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laboratory abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18387463\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H117452326\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/1247\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1247|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/32/527\" title=\"figure 1\">",
"      Reitan Test - part A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/49/37662\" title=\"figure 2\">",
"      Reitan Test - part B",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/1247|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/0/21515\" title=\"table 1\">",
"      Indications for paracentesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/61/18395\" title=\"table 2\">",
"      Signs and symptoms of SBP",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12296?source=related_link\">",
"      Diagnosis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34197?source=related_link\">",
"      Pathogenesis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/1/4121?source=related_link\">",
"      Treatment and prophylaxis of spontaneous bacterial peritonitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_0_7173="Normal biceps tendon sonogr";
var content_f7_0_7173=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F72784&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F72784&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Normal biceps tendon sonogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 385px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This transverse sonogram of a normal bicipital tendon in the bicipital groove of the proximal humerus shows a round cross section and multiple echogenic dots.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of George AW Bruyn, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7173=[""].join("\n");
var outline_f7_0_7173=null;
var title_f7_0_7174="Metastatic ca to pleura I CT";
var content_f7_0_7174=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61913%7EPULM%2F79085&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61913%7EPULM%2F79085&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Metastatic breast cancer to pleura",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 338px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Status post right mastectomy. CT scan shows small left pleural effusion and larger right pleural effusion with tumor masses, leading to cardiomediastinal shift to the left. Sclerosis of the sternum is due to osteoblastic metastatic disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Metastatic breast cancer to pleura and pericardium",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 295px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Status post bilateral mastectomies. CT scan shows bilateral pleural effusions, free on the left, and loculated on the right. High attenuation material in the right hemithorax is due to talcum from an attempted pleurodesis. Tumor nodules are seen in the pericardium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7174=[""].join("\n");
var outline_f7_0_7174=null;
var title_f7_0_7175="Light microscopy chorioCA";
var content_f7_0_7175=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F57642&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F57642&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Choriocarcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a testicular choriocarcinoma. The central smaller cytotrophoblast cells with clear cytoplasm are surrounded by the much larger syncytiotrophoblastic giant cells (black arrow) that have huge, convoluted, pleomorphic nuclei and abundant eosinophilic cytoplasm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Weinstein, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7175=[""].join("\n");
var outline_f7_0_7175=null;
var title_f7_0_7176="Poison oak PI";
var content_f7_0_7176=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F68304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F68304&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Poison oak",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7176=[""].join("\n");
var outline_f7_0_7176=null;
var title_f7_0_7177="Hypouricemia: Causes and clinical significance";
var content_f7_0_7177=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hypouricemia: Causes and clinical significance",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/0/7177/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7177/contributors\">",
"     David B Mount, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/0/7177/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7177/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/0/7177/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7177/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/0/7177/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypouricemia is arbitrarily defined as a serum urate concentration of less than 2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (119",
"    <span class=\"nowrap\">",
"     micromol/L).",
"    </span>",
"    It occurs in about 2 percent of hospitalized patients and less than 0.5 percent of the normal population [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/1\">",
"     1",
"    </a>",
"    ]. Hypouricemia may be caused by decreased uric acid production, uric acid oxidation due to treatment with uricase, or decreased renal tubular reabsorption due to inherited or acquired disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/2\">",
"     2",
"    </a>",
"    ]. There are no known abnormalities of intestinal uricolysis that produce hypouricemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/42/24230?source=see_link\">",
"     \"Uric acid balance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypouricemia has been thought of as a biochemical disorder with no clinical significance other than as a marker of underlying disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/3\">",
"     3",
"    </a>",
"    ]. However, individuals with renal tubular urate wasting may have an increased incidence of acute kidney injury (previously called acute renal failure). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/49/42773?source=see_link\">",
"     \"Definition of acute kidney injury (acute renal failure)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3188296\">",
"    <span class=\"h1\">",
"     DECREASED PRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decreased uric acid production can be caused by several rare inherited disorders of purine synthesis and catabolism and, more commonly, by acquired deficiency of xanthine oxidase due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    therapy or liver disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3187616\">",
"    <span class=\"h2\">",
"     Inherited disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inherited disorders resulting in decreased uric acid production include hereditary xanthinuria and purine nucleosidase phosphorylase deficiency:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hereditary xanthinuria &minus; Xanthine oxidase catalyzes the conversion of hypoxanthine to xanthine and of xanthine to uric acid. Deficiency of xanthine oxidase, which is inherited as an autosomal recessive trait, results in hereditary xanthinuria [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]. Striking hypouricemia is seen with levels usually below 1",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (59.5",
"      <span class=\"nowrap\">",
"       micromol/L).",
"      </span>",
"      Increased urinary excretion of relatively insoluble xanthine leads to the development of xanthine stones in approximately one-third of patients. Xanthine stones are managed with fluids to increase the urine output (which reduces the urine xanthine concentration) and with alkali administration (which modestly increases xanthine solubility) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/6\">",
"       6",
"      </a>",
"      ]. In a smaller number of patients, deposition of xanthine crystals in skeletal muscle produces myopathic symptoms.",
"      <br/>",
"      <br/>",
"      The diagnosis is suspected by the finding of hypouricemia, reduced urinary uric acid excretion, and increased xanthine excretion; it is confirmed by liver or intestinal biopsy with measurement of enzyme activity.",
"     </li>",
"     <li>",
"      Purine nucleoside phosphorylase deficiency &minus; Purine nucleoside phosphorylase (PNP) catalyzes the reaction in which inosine, deoxyinosine, and deoxyguanosine undergo phosphorylation to purine bases. PNP deficiency results in hypouricemia, developmental retardation, defective cellular immunity with lymphopenia, deceased T-cells, and recurrent infections. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25637?source=see_link\">",
"       \"Purine nucleoside phosphorylase deficiency\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3188304\">",
"    <span class=\"h2\">",
"     Acquired disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acquired deficiency of xanthine oxidase is considerably more common than inherited disorders of decreased production. The major acquired causes of xanthine oxidase deficiency are drugs (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    ), and severe liver disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Xanthine oxidase inhibitors &minus;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"       Allopurinol",
"      </a>",
"      (and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/62/29668?source=see_link\">",
"       febuxostat",
"      </a>",
"      ) reduces the formation of uric acid by inhibiting xanthine oxidase activity and lowering intracellular phosphoribosyl pyrophosphate levels. This is the most common cause of hypouricemia, although it is unusual for the uric acid level to fall below 2.5",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (149",
"      <span class=\"nowrap\">",
"       micromol/L).",
"      </span>",
"     </li>",
"     <li>",
"      Liver disease &minus; With severe hepatocellular injury, there may be sufficient loss of hepatic xanthine oxidase activity to produce hypouricemia. A renal tubular defect in urate reabsorption may also contribute [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13090614\">",
"    <span class=\"h1\">",
"     URIC ACID OXIDATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike most animal species, humans lack urate oxidase (uricase). Thus, in humans, uric acid is an end-product of metabolism. Derivatives of uricase (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/54/34661?source=see_link\">",
"     rasburicase",
"    </a>",
"    ), which catalyzes the oxidation of uric acid to allantoin, are widely used in the prevention and treatment of acute kidney injury in tumor lysis syndrome. A \"PEGylated\" rasburicase may be used in the management of refractory gout [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/8\">",
"     8",
"    </a>",
"    ], causing profound hypouricemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3188312\">",
"    <span class=\"h1\">",
"     INCREASED URINARY EXCRETION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased urinary excretion of uric acid can be seen with familial hypouricemia (an inherited disorder) and in a variety of acquired conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Familial renal hypouricemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Familial hypouricemia, which is caused by a defect in renal tubular urate transport, is a rare syndrome transmitted as an autosomal trait [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/9-20\">",
"     9-20",
"    </a>",
"    ]. The defect appears to be more common in non-Ashkenazi Jews and Japanese individuals. In a report of 3258 Japanese outpatients, for example, renal hyperuricosuria and persistent hypouricemia were found in four (0.12 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/11\">",
"     11",
"    </a>",
"    ]. The mechanism for hyperuricosuria has been studied using the anti-uricosuric agent,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"     pyrazinamide",
"    </a>",
"    , and the uricosuric drugs, benzbromarone and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/18/37157?source=see_link\">",
"     probenecid",
"    </a>",
"    . Most patients exhibit attenuated responses to both pyrazinamide and uricosurics, while a minority have an attenuated response to uricosurics but a preserved anti-uricosuric response to pyrazinamide [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/20\">",
"     20",
"    </a>",
"    ]. The basic aspects of renal urate handling are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/42/24230?source=see_link&amp;anchor=H5#H5\">",
"     \"Uric acid balance\", section on 'Urinary excretion'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The underlying defect in the great majority of patients is a mutation in a gene called SLC22A12 that encodes for a renal urate-anion exchanger named URAT1 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. URAT1 is expressed in the luminal membrane of the proximal tubular cells and is responsible for a large portion of proximal urate reabsorption (",
"    <a class=\"graphic graphic_figure graphicRef83926 \" href=\"UTD.htm?32/24/33166\">",
"     figure 1",
"    </a>",
"    ). The residual apical uptake of urate is likely mediated by the OAT4 (SLC22A11) and OAT10 (SLC22A13) urate-anion exchangers [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/23,24\">",
"     23,24",
"    </a>",
"    ], in addition to GLUT9S (see below).",
"   </p>",
"   <p>",
"    Familial renal hypouricemia has also been described in patients with mutations in the SLC2A9 gene, which encodes a high capacity urate transporter called GLUT9. Two GLUT9 variants include the short (GLUT9S) and long (GLUT9L) forms [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. Urate reabsorption from the tubular lumen into the cell is mediated by URAT1 and other anion exchangers, as mentioned above, and by GLUT9S. Uric acid efflux from the cell across the basolateral membrane appears to be mediated solely by basolateral GLUT9L (",
"    <a class=\"graphic graphic_figure graphicRef83926 \" href=\"UTD.htm?32/24/33166\">",
"     figure 1",
"    </a>",
"    ); the basolateral urate exchangers OAT1 and OAT3 function as the basolateral entry site for urate secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/28\">",
"     28",
"    </a>",
"    ], with no evident role in urate absorption across the proximal tubule (",
"    <a class=\"graphic graphic_figure graphicRef83925 \" href=\"UTD.htm?22/40/23182\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The severity of the hypouricemia varies with the genetic defect:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients homozygous for URAT1 mutations typically have serum urate concentrations below 1.0",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (59.5",
"      <span class=\"nowrap\">",
"       micromol/L)",
"      </span>",
"      and a partial uric acid reabsorption defect with fractional excretion of urate that ranges between 40 and 90 percent. The uricosuric effect of benzbromarone and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/18/37157?source=see_link\">",
"       probenecid",
"      </a>",
"      is abolished in these patients, as is the anti-uricosuric effect of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"       pyrazinamide",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/22\">",
"       22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/42/24230?source=see_link&amp;anchor=H5#H5\">",
"       \"Uric acid balance\", section on 'Urinary excretion'",
"      </a>",
"      .) Clinical abnormalities are unusual, although nephrolithiasis is three to four times more common than in the general population, and a few cases of exercise-induced acute kidney injury have been described [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/29\">",
"       29",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Acute kidney injury'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Loss-of-function mutations in GLUT9 cause more severe hypouricemia (close to zero) in homozygous individuals and are associated with a high incidence of renal calculi and exercise-induced acute kidney injury. In contrast to patients with mutations in URAT1, the loss of function of GLUT9 precludes uric acid reabsorption by all of the apical transporters (including URAT1) due to complete inhibition of basolateral uric acid efflux from the cell. The net effect is a fractional urate excretion of 100 to 150 percent; values above 100 percent reflect urate secretion. Urate secretion is mediated by a separate set of apical and basolateral urate transporters (",
"      <a class=\"graphic graphic_figure graphicRef83925 \" href=\"UTD.htm?22/40/23182\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/42/24230?source=see_link&amp;anchor=H5#H5\">",
"       \"Uric acid balance\", section on 'Urinary excretion'",
"      </a>",
"      .) The anti-uricosuric effect of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"       pyrazinamide",
"      </a>",
"      is retained in these patients [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/26\">",
"       26",
"      </a>",
"      ], unlike those with URAT1 deficiency. Patients heterozygous for a GLUT9 loss-of-function mutation have moderately reduced serum uric acid levels. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Complications'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3188323\">",
"    <span class=\"h2\">",
"     Acquired disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypouricemia due to increased urinary excretion of uric acid results from a variety of conditions, as outlined below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Fanconi syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uric acid reabsorption in the proximal tubule can be decreased in the Fanconi syndrome, along with defects in the reabsorption of phosphate, glucose, and amino acids [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/30\">",
"     30",
"    </a>",
"    ]. This syndrome has multiple causes, including cystinosis, multiple myeloma, and various drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/18/12584?source=see_link\">",
"     \"Cystinosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27400?source=see_link\">",
"     \"Types of renal disease in multiple myeloma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Volume expansion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Expansion of the extracellular fluid volume can be associated with hypouricemia by decreasing proximal tubular reabsorption of urate [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/31\">",
"     31",
"    </a>",
"    ]. This is most commonly seen in patients receiving large volumes of intravenous fluids and in patients with primary polydipsia or the syndrome of inappropriate antidiuretic hormone (SIADH) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/32-35\">",
"     32-35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=see_link&amp;anchor=H9#H9\">",
"     \"Evaluation of the patient with hyponatremia\", section on 'Serum uric acid and urea concentrations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypouricemia can develop in patients receiving large volumes of intravenous fluids because the reabsorption of urate by the proximal tubule parallels that of sodium [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/36\">",
"     36",
"    </a>",
"    ]. Restriction of sodium intake reduces both sodium and urate excretion and can produce hyperuricemia; in contrast, excess sodium intake (as with large volumes of intravenous fluids) increases both sodium and urate excretion and can produce hypouricemia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/37-40\">",
"     37-40",
"    </a>",
"    ]. Several short-term studies have shown that serum urate on a high-sodium diet (170 to 260",
"    <span class=\"nowrap\">",
"     mmol/day)",
"    </span>",
"    was 1.0 to 2.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    lower than on a low-sodium diet (20 to 50",
"    <span class=\"nowrap\">",
"     mmol/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/37-40\">",
"     37-40",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Water restriction resolves both the hyponatremia and hypouricemia in the SIADH, suggesting a primary role for volume expansion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/33\">",
"     33",
"    </a>",
"    ]. Both the vasopressin 2 (V2) and vasopressin 1 (V1) receptors may be important in the hypouricemia associated with SIADH:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Activation of the vasopressin 2 (V2) receptor by either natively produced vasopressin or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"       desmopressin",
"      </a>",
"      (a vasopressin analog that only stimulates the V2 receptor) leads to sodium absorption by the principal cells of the connecting tubule and cortical collecting duct [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/41-43\">",
"       41-43",
"      </a>",
"      ]. The ensuing sodium retention reduces the reabsorption of sodium by the proximal tubule. As just discussed, the reduction in proximal sodium reabsorption is associated with a similar reduction in proximal urate reabsorption, which can produce hypouricemia. &nbsp;",
"     </li>",
"     <li>",
"      However, stimulation of the V1 receptor may also contribute to the uric acid wasting via an uncertain mechanism. The importance of this receptor is suggested by the observation that the induction of hyponatremia by the administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"       desmopressin",
"      </a>",
"      produces a significantly smaller fall in the serum uric acid concentration (29 versus 53 percent) than seen in patients with a similar degree of hyponatremia due to the SIADH (in which the native hormone stimulates both the V1 and V2 receptors) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/44\">",
"       44",
"      </a>",
"      ]. Consistent with this hypothesis, lack of V1 receptor activity in patients with central diabetes insipidus has been associated with hyperuricemia that is not improved with desmopressin therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hypouricemia may also occur in some patients with thiazide-induced hyponatremia in whom water overload (rather than volume contraction) is the primary problem [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/31/502?source=see_link\">",
"     \"Diuretic-induced hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Intracranial disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypouricemia due to increased urate clearance has been described in patients with intracranial disease. One study, for example, evaluated 29 consecutive neurosurgical patients: 18 had an elevated fractional excretion of urate, and seven had hypouricemia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/47\">",
"     47",
"    </a>",
"    ]. In some patients, the hypouricemia is associated with renal sodium wasting and hyponatremia, a disorder that has been called cerebral salt-wasting [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/2,35,48\">",
"     2,35,48",
"    </a>",
"    ]. In contrast to the hypouricemia seen in the SIADH, the hypouricemia in cerebral salt-wasting should not be corrected by water restriction because the primary problem appears to be a humoral substance released from the brain rather than volume expansion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/45\">",
"     45",
"    </a>",
"    ]. Alternatively, the apparent salt-wasting and increased urate clearance may reflect volume expansion due to saline, which is commonly administered to neurosurgical patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8567?source=see_link\">",
"     \"Cerebral salt-wasting\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation of the patient with hyponatremia\", section on 'Findings in SIADH'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Acquired immunodeficiency syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased fractional excretion of urate and hypouricemia may be seen in patients with AIDS [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. In a study of 96 patients, for example, hypouricemia was found in 21 (22 percent) and was associated with cerebral atrophy in 12 who underwent cranial CT [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/50\">",
"     50",
"    </a>",
"    ]. Risk factors for hypouricemia in these and other patients include disseminated disease, central nervous system infection, and high-dose therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. The development of hypouricemia may be a poor prognostic factor [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of drugs interfere with net renal tubular urate reabsorption and lower serum uric acid levels (",
"    <a class=\"graphic graphic_table graphicRef64646 \" href=\"UTD.htm?17/11/17595\">",
"     table 1",
"    </a>",
"    ). The most common are high-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    and high-dose salicylate therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/52-54\">",
"     52-54",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/23/17784?source=see_link\">",
"     Fenofibrate",
"    </a>",
"    also inhibits URAT1 with a uricosuric and hypouricemic effect [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/55\">",
"     55",
"    </a>",
"    ]. In most instances, the serum uric acid concentration does not fall below normal levels. The uricosuric action of the angiotensin II receptor blocker,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"     losartan",
"    </a>",
"    , has been used to treat the hyperuricemia associated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    in heart transplant recipients; this effect appears to be more pronounced than that seen with an angiotensin-converting enzyme inhibitor [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/56\">",
"     56",
"    </a>",
"    ]. The uricosuria appears to occur via the inhibition of URAT1, the function of which is described above [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Familial renal hypouricemia'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11797806\">",
"    <span class=\"h3\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory cytokines appear to reduce net renal tubular reabsorption of urate, leading to hypouricemia. Urate levels are typically lower in the context of acute gout flares [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/58\">",
"     58",
"    </a>",
"    ] due to an increase in urate excretion that has been linked to increases in cytokines and other inflammatory stimuli [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/59\">",
"     59",
"    </a>",
"    ]. More severe renal hypouricemia has been described in sepsis. As an example, 16 out of 43 Taiwanese patients with SARS were shown to develop marked renal hypouricemia (mean serum uric acid, 1.7",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [100",
"    <span class=\"nowrap\">",
"     micromol/L]),",
"    </span>",
"    in association with elevated interleukin-8 levels [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other causes have been associated with hypouricemia due to increased urate excretion:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/61\">",
"       61",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"       Total parenteral nutrition",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/62\">",
"       62",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Malignancies, including Hodgkin lymphoma [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/63-65\">",
"       63-65",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Diabetes mellitus [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/66,67\">",
"       66,67",
"      </a>",
"      ]; it is not clear if decreased urate reabsorption is a function of glucosuria in these patients",
"     </li>",
"     <li>",
"      Amanita phalloides poisoning [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/68\">",
"       68",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most patients with hypouricemia of any cause are asymptomatic, two complications related to renal hypouricemia can occur: acute kidney injury and nephrolithiasis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Acute kidney injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increased incidence of acute kidney injury (AKI), often following exercise, has been described in patients with familial renal hypouricemia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/22,69-73\">",
"     22,69-73",
"    </a>",
"    ]. The largest reported experience comes from a review of 54 patients with renal hypouricemia, approximately 90 percent of whom were male [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/69\">",
"     69",
"    </a>",
"    ]. Episodes of AKI most often occurred after strenuous exercise, such as a short distance race. The initial symptoms were severe loin or abdominal pain and nausea, which usually developed within 6 to 12 hours after exercise. At presentation to medical care, the mean serum creatinine was 5.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (486",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    and the mean serum uric acid concentration was normal (4.4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [262",
"    <span class=\"nowrap\">",
"     micromol/L]),",
"    </span>",
"    which was felt to be at least in part due to the renal failure. After recovery, the serum uric acid fell to 0.7",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (42",
"    <span class=\"nowrap\">",
"     micromol/L).",
"    </span>",
"    Recovery of renal function occurred in all patients, although some required hemodialysis. At follow-up, 13 patients (24 percent) developed recurrent AKI. In some patients, repeated episodes of AKI may lead to chronic kidney disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data are limited on the frequency of AKI following exercise in patients with renal hypouricemia. The increase in relative risk was assessed in a study of 13 patients presenting with AKI following exercise, three of whom (23 percent) had renal hypouricemia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/70\">",
"     70",
"    </a>",
"    ]. This rate exceeded the expected incidence of familial renal hypouricemia by 200-fold. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Familial renal hypouricemia'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Two major pathogenetic mechanisms have been proposed for exercise-associated AKI in renal hypouricemia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oxidative stress from reactive oxygen species generated during exercise, leading to renal vasoconstriction, ischemia, oxidant injury [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/74\">",
"       74",
"      </a>",
"      ], and acute tubular injury (also called acute tubular necrosis, or ATN).",
"     </li>",
"     <li>",
"      Increased uric acid production, leading to increased uric acid excretion and precipitation in the tubules, as occurs in tumor lysis syndrome and other causes of acute and marked tissue breakdown. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19481?source=see_link&amp;anchor=H491545#H491545\">",
"       \"Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors\", section on 'Pathogenesis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=see_link&amp;anchor=H2#H2\">",
"       \"Uric acid renal diseases\", section on 'Acute uric acid nephropathy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The majority of reported renal biopsies in exercise-associated AKI in renal hypouricemia have demonstrated ATN without intratubular uric acid precipitation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/69,75\">",
"     69,75",
"    </a>",
"    ]. It is hypothesized that the reduction in circulating uric acid, which is a known antioxidant [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/76\">",
"     76",
"    </a>",
"    ], impairs the ability of the kidney to cope with the increase in oxidative stress associated with strenuous exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/77\">",
"     77",
"    </a>",
"    ]. In a patient with renal hypouricemia and exercise-associated AKI, for example, both an acute increase in reactive oxygen species and a decreased antioxidant potential capacity were demonstrated soon after the initiation of exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/78\">",
"     78",
"    </a>",
"    ]. Consequently, many patients with a history of exercise-associated AKI are treated with oral vitamin C and vitamin E in an attempt to increase serum antioxidant capacity [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prolonged or intense exercise is also associated with an elevation in uric acid production, most likely due to muscle adenosine triphosphate (ATP) utilization. The subsequent rise in adenosine diphosphate (ADP) leads to an increase in the production of hypoxanthine, which is then converted to uric acid in the liver, leading to increases in serum uric acid and uric acid excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. Volume depletion during exercise can lead to a reduction in urine volume, which might promote uric acid precipitation in the tubules. Uric acid precipitation in the tubules can also occur with other causes of an acute increase in uric acid excretion, including high-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The theory of uric acid precipitation is supported by the renal biopsy demonstration of renal tubular obstruction by uric acid crystals in a single case report of exercise-induced AKI [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/81\">",
"     81",
"    </a>",
"    ] and by an increased prevalence of uric acid nephrolithiasis in patients with renal hypouricemia. (See",
"    <a class=\"local\" href=\"#H559528\">",
"     'Uric acid stone formation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Further evidence comes from a study of a Pakistani patient with recurrent exercise-induced AKI [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/72\">",
"     72",
"    </a>",
"    ]. This patient and four normals were studied with and without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    during a physical fitness test. Uric acid excretion without allopurinol increased from 0.46",
"    <span class=\"nowrap\">",
"     mg/min",
"    </span>",
"    at baseline to 1.49",
"    <span class=\"nowrap\">",
"     mg/min",
"    </span>",
"    at four hours after exercise, and the patient developed AKI. Uric acid excretion in controls was also 0.46",
"    <span class=\"nowrap\">",
"     mg/min",
"    </span>",
"    at baseline but only increased to 0.59",
"    <span class=\"nowrap\">",
"     mg/min",
"    </span>",
"    at four hours after exercise. After five days of allopurinol, the patient underwent the same fitness test without experiencing an increase in urate excretion or AKI. However, allopurinol is also an antioxidant, which could have explained the protection against AKI [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H559528\">",
"    <span class=\"h2\">",
"     Uric acid stone formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with renal hypouricemia are at increased risk for nephrolithiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/15-18,25,82\">",
"     15-18,25,82",
"    </a>",
"    ]. In two series of 19 patients with familial renal hypouricemia, five (26 percent) had a history of kidney stones [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/25,82\">",
"     25,82",
"    </a>",
"    ]. Most of these reports described uric acid stones and successful treatment with urinary alkalinization [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. However, hyperuricosuria may predispose to calcium oxalate stones [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/83\">",
"     83",
"    </a>",
"    ], which have also been described in patients with renal hypouricemia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Familial renal hypouricemia'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/62/3047?source=see_link&amp;anchor=H5#H5\">",
"     \"Uric acid nephrolithiasis\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with renal hypouricemia have increased fractional excretion of urate but, in theory, should have normal 24-hour urinary excretion, since urate production (which is unchanged in renal hypouricemia) and urate excretion are roughly equal in the steady state. Thus, an increased risk of uric acid stones would seem counterintuitive. However, many patients with familial renal hypouricemia have moderate or marked hyperuricosuria, possibly due to diversion of urate elimination from the intestine to the urine (ie, less gastrointestinal clearance of the daily uric acid load in favor or more urinary clearance) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/20\">",
"     20",
"    </a>",
"    ]. How this might occur is not known. In addition, some of these patients have hypercalciuria via an uncertain mechanism, which is another risk factor for stone formation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7177/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10360291\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypouricemia is arbitrarily defined as a serum urate concentration of less than 2",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (119",
"      <span class=\"nowrap\">",
"       micromol/L).",
"      </span>",
"      It is a fairly common disorder, occurring in about 2 percent of hospitalized patients and less than 0.5 percent of the normal population. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypouricemia can be caused by decreased uric acid production, uric acid oxidation due to treatment with uricase, or enhanced urate excretion.",
"     </li>",
"     <li>",
"      Decreased uric acid production can be due to rare inherited disorders of purine synthesis and catabolism (hereditary xanthinuria or xanthine oxidase deficiency) or, more commonly, acquired deficiency of xanthine oxidase (as with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"       allopurinol",
"      </a>",
"      or severe liver disease). (See",
"      <a class=\"local\" href=\"#H3188296\">",
"       'Decreased production'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Increased urinary uric acid excretion may be seen in the following disorders and with certain drugs (see",
"      <a class=\"local\" href=\"#H3188312\">",
"       'Increased urinary excretion'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Familial renal hypouricemia, due to mutations in URAT1 or GLUT9, which encode for proteins responsible for urate reabsorption in the proximal tubule. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Familial renal hypouricemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fanconi syndrome, in which uric acid reabsorption in the proximal tubule is decreased, along with reductions in the reabsorption of one or more of the following: phosphate, glucose, potassium, bicarbonate, and amino acids. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Fanconi syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Expansion of the extracellular fluid volume, most commonly seen in patients receiving large volumes of intravenous fluids, those with primary polydipsia, and in the syndrome of inappropriate antidiuretic hormone secretion. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Volume expansion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intracranial disease in association with renal sodium wasting and hyponatremia (cerebral salt-wasting). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Intracranial disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      AIDS, which may be related to intracranial disease and tends to correlate with disseminated disease and a poor prognosis. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Acquired immunodeficiency syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Drugs, such as high-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      , high-dose salicylate, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      (",
"      <a class=\"graphic graphic_table graphicRef64646 \" href=\"UTD.htm?17/11/17595\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Drugs'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two complications related to renal hypouricemia can occur: acute kidney injury and nephrolithiasis. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7726972\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and editors would like to thank Dr. Zalman Agus, who contributed to previous versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/1\">",
"      Ogino K, Hisatome I, Saitoh M, et al. Clinical significance of hypouricemia in hospitalized patients. J Med 1991; 22:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/2\">",
"      Maesaka JK, Fishbane S. Regulation of renal urate excretion: a critical review. Am J Kidney Dis 1998; 32:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/3\">",
"      Ramsdell CM, Kelley WN. The clinical significance of hypouricemia. Ann Intern Med 1973; 78:239.",
"     </a>",
"    </li>",
"    <li>",
"     Holmes EW, Wyngaarden JB. Hereditary xanthinuria. In: The Metabolic Basis of Inherited Disease, 6th ed, Scriver C, Beaudet AL, Sly WS, et al (Eds), McGraw-Hill, New York 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/5\">",
"      Levartovsky D, Lagziel A, Sperling O, et al. XDH gene mutation is the underlying cause of classical xanthinuria: a second report. Kidney Int 2000; 57:2215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/6\">",
"      Seegmiller JE. Xanthine stone formation. Am J Med 1968; 45:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/7\">",
"      Michelis MF, Warms PC, Fusco RD, Davis BB. Hypouricemia and hyperuricosuria in Laennec cirrhosis. Arch Intern Med 1974; 134:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/8\">",
"      Sundy JS, Becker MA, Baraf HS, et al. Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. Arthritis Rheum 2008; 58:2882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/9\">",
"      Greene ML, Marcus R, Aurbach GD, et al. Hypouricemia due to isolated renal tubular defect. Dalmatian dog mutation in man. Am J Med 1972; 53:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/10\">",
"      Khachadurian AK, Arslanian MJ. Hypouricemia due to renal uricosuria. A case study. Ann Intern Med 1973; 78:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/11\">",
"      Hisatome I, Ogino K, Kotake H, et al. Cause of persistent hypouricemia in outpatients. Nephron 1989; 51:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/12\">",
"      Barajas de Frutos D, Bravo Manche&ntilde;o B, Palomino Urda N, Pedrero Vera J. Familial hypouricaemia due to an isolated tubular defect of urate reabsorption. Pediatr Nephrol 1993; 7:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/13\">",
"      Hisatome I, Kato T, Miyakoda H, et al. Renal hypouricemia with both drug-insensitive secretion and defective reabsorption of urate: a novel type of renal hypouricemia. Nephron 1993; 64:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/14\">",
"      Shichiri M, Iwamoto H, Shiigai T. Hypouricemia due to increased tubular urate secretion. Nephron 1987; 45:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/15\">",
"      Frank M, Many M, Sperling O. Familial renal hypouricaemia: two additional cases with uric acid lithiasis. Br J Urol 1979; 51:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/16\">",
"      Hedley JM, Phillips PJ. Familial hypouricaemia associated with renal tubular uricosuria and uric acid calculi: case report. J Clin Pathol 1980; 33:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/17\">",
"      Gofrit O, Verstandig AG, Pode D. Bilateral obstructing ureteral uric acid stones in an infant with hereditary renal hypouricemia. J Urol 1993; 149:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/18\">",
"      Hisatome I, Tanaka Y, Kotake H, et al. Renal hypouricemia due to enhanced tubular secretion of urate associated with urolithiasis: successful treatment of urolithiasis by alkalization of urine K+, Na(+)-citrate. Nephron 1993; 65:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/19\">",
"      Iwai N, Mino Y, Hosoyamada M, et al. A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int 2004; 66:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/20\">",
"      Sperling O. Hereditary renal hypouricemia. Mol Genet Metab 2006; 89:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/21\">",
"      Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/22\">",
"      Ichida K, Hosoyamada M, Hisatome I, et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004; 15:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/23\">",
"      Hagos Y, Stein D, Ugele B, et al. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 2007; 18:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/24\">",
"      Bahn A, Hagos Y, Reuter S, et al. Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem 2008; 283:16332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/25\">",
"      Dinour D, Gray NK, Campbell S, et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol 2010; 21:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/26\">",
"      Matsuo H, Chiba T, Nagamori S, et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet 2008; 83:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/27\">",
"      Caulfield MJ, Munroe PB, O'Neill D, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008; 5:e197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/28\">",
"      Eraly SA, Vallon V, Rieg T, et al. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics 2008; 33:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/29\">",
"      Uribarri J, Oh MS. Renal hypouricemia and absorptive hypercalciuria: a real syndrome. Nephron 1993; 63:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/30\">",
"      Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug-induced Fanconi's syndrome. Am J Kidney Dis 2003; 41:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/31\">",
"      Weinman EJ, Eknoyan G, Suki WN. The influence of the extracellular fluid volume on the tubular reabsorption of uric acid. J Clin Invest 1975; 55:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/32\">",
"      Peretz A, Decaux G, Famaey JP. Hypouricemia and intravenous infusions. J Rheumatol 1983; 10:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/33\">",
"      Beck LH. Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1979; 301:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/34\">",
"      Decaux G, Schlesser M, Coffernils M, et al. Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol 1994; 42:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/35\">",
"      Decaux G, Prospert F, Namias B, Soupart A. Utility of serum uric acid determination in the differential diagnosis between central diabetes insipidus and primary polydipsia (abstract). J Am Soc Nephrol 1996; 7:1348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/36\">",
"      Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993; 270:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/37\">",
"      Egan BM, Lackland DT. Biochemical and metabolic effects of very-low-salt diets. Am J Med Sci 2000; 320:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/38\">",
"      Masugi F, Ogihara T, Hashizume K, et al. Changes in plasma lipids and uric acid with sodium loading and sodium depletion in patients with essential hypertension. J Hum Hypertens 1988; 1:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/39\">",
"      Del R&iacute;o A, Rodr&iacute;guez-Villamil JL. Metabolic effects of strict salt restriction in essential hypertensive patients. J Intern Med 1993; 233:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/40\">",
"      Ruppert M, Diehl J, Kolloch R, et al. Short-term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults. Klin Wochenschr 1991; 69 Suppl 25:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/41\">",
"      Ecelbarger CA, Kim GH, Terris J, et al. Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney. Am J Physiol Renal Physiol 2000; 279:F46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/42\">",
"      Bugaj V, Pochynyuk O, Stockand JD. Activation of the epithelial Na+ channel in the collecting duct by vasopressin contributes to water reabsorption. Am J Physiol Renal Physiol 2009; 297:F1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/43\">",
"      Bankir L, Fernandes S, Bardoux P, et al. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 2005; 16:1920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/44\">",
"      Decaux G, Namias B, Gulbis B, Soupart A. Evidence in hyponatremia related to inappropriate secretion of ADH that V1 receptor stimulation contributes to the increase in renal uric acid clearance. J Am Soc Nephrol 1996; 7:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/45\">",
"      Decaux G, Prospert F, Namias B, Soupart A. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia. Am J Med 1997; 103:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/46\">",
"      Sonnenblick M, Rosin AJ. Significance of the measurement of uric acid fractional clearance in diuretic induced hyponatraemia. Postgrad Med J 1986; 62:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/47\">",
"      Maesaka JK, Venkatesan J, Piccione JM, et al. Abnormal urate transport in patients with intracranial disease. Am J Kidney Dis 1992; 19:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/48\">",
"      Maesaka JK, Batuman V, Yudd M, et al. Hyponatremia and hypouricemia: differentiation from SIADH. Clin Nephrol 1990; 33:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/49\">",
"      Sterns RH, Silver SM. Cerebral salt wasting versus SIADH: what difference? J Am Soc Nephrol 2008; 19:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/50\">",
"      Maesaka JK, Cusano AJ, Thies HL, et al. Hypouricemia in acquired immunodeficiency syndrome. Am J Kidney Dis 1990; 15:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/51\">",
"      Collazos J, Blanco MS, Guerra E, et al. Sequential evaluation of serum urate concentrations in AIDS patients with infections of the central nervous system. Clin Chem Lab Med 2000; 38:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/52\">",
"      Chertow GM, Seifter JL, Christiansen CL, O'Donnell WJ. Trimethoprim-sulfamethoxazole and hypouricemia. Clin Nephrol 1996; 46:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/53\">",
"      YU TF, GUTMAN AB. Paradoxical retention of uric acid by uricosuric drugs in low dosage. Proc Soc Exp Biol Med 1955; 90:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/54\">",
"      YU TF, GUTMAN AB. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest 1959; 38:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/55\">",
"      Uetake D, Ohno I, Ichida K, et al. Effect of fenofibrate on uric acid metabolism and urate transporter 1. Intern Med 2010; 49:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/56\">",
"      Minghelli G, Seydoux C, Goy JJ, Burnier M. Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients. Transplantation 1998; 66:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/57\">",
"      Hamada T, Ichida K, Hosoyamada M, et al. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients. Am J Hypertens 2008; 21:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/58\">",
"      AYVAZIAN JH, AYVAZIAN IF. CHANGES IN SERUM AND URINARY URIC ACID WITH THE DEVELOPMENT OF SYMPTOMATIC GOUT. J Clin Invest 1963; 42:1835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/59\">",
"      Urano W, Yamanaka H, Tsutani H, et al. The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol 2002; 29:1950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/60\">",
"      Wu VC, Huang JW, Hsueh PR, et al. Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome. Am J Kidney Dis 2005; 45:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/61\">",
"      Lind T, Godfrey KA, Otun H, Philips PR. Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol 1984; 91:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/62\">",
"      Derus CL, Levinson DJ, Bowman B, et al. Altered fractional excretion of uric acid during total parenteral nutrition. J Rheumatol 1987; 14:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/63\">",
"      Cooper DS. Oat-cell carcinoma and severe hypouricemia. N Engl J Med 1973; 288:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/64\">",
"      Magoula I, Tsapas G, Kountouras J, et al. Cholangiocarcinoma and severe renal hypouricemia: a study of the renal mechanisms. Am J Kidney Dis 1991; 18:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/65\">",
"      Bennett JS, Bond J, Singer I, Gottlieb AJ. Hypouricemia in Hodgkin's disease. Ann Intern Med 1972; 76:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/66\">",
"      Shichiri M, Iwamoto H, Shiigai T. Diabetic renal hypouricemia. Arch Intern Med 1987; 147:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/67\">",
"      Magoula I, Tsapas G, Paletas K, Mavromatidis K. Insulin-dependent diabetes and renal hypouricemia. Nephron 1991; 59:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/68\">",
"      Zawadzki J, Jankowska I, Moszczyska A, Januszewicz P. Hypouricemia due to increased tubular secretion of urate in children with Amanita phalloides poisoning. Nephron 1993; 65:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/69\">",
"      Ohta T, Sakano T, Igarashi T, et al. Exercise-induced acute renal failure associated with renal hypouricaemia: results of a questionnaire-based survey in Japan. Nephrol Dial Transplant 2004; 19:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/70\">",
"      Ishikawa I, Sakurai Y, Masuzaki S, et al. Exercise-induced acute renal failure in 3 patients with renal hypouricemia. Nihon Jinzo Gakkai Shi 1990; 32:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/71\">",
"      Murakami T, Kawakami H, Fukuda M, Furukawa S. Patients with renal hypouricemia are prone to develop acute renal failure--why? Clin Nephrol 1995; 43:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/72\">",
"      Yeun JY, Hasbargen JA. Renal hypouricemia: prevention of exercise-induced acute renal failure and a review of the literature. Am J Kidney Dis 1995; 25:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/73\">",
"      Mima A, Ichida K, Matsubara T, et al. Acute renal failure after exercise in a Japanese sumo wrestler with renal hypouricemia. Am J Med Sci 2008; 336:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/74\">",
"      Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/75\">",
"      Ohta T, Sakano T, Ogawa T, et al. Exercise-induced acute renal failure with renal hypouricemia: a case report and a review of the literature. Clin Nephrol 2002; 58:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/76\">",
"      Peden DB, Hohman R, Brown ME, et al. Uric acid is a major antioxidant in human nasal airway secretions. Proc Natl Acad Sci U S A 1990; 87:7638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/77\">",
"      Vollaard NB, Shearman JP, Cooper CE. Exercise-induced oxidative stress:myths, realities and physiological relevance. Sports Med 2005; 35:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/78\">",
"      Kaneko K, Taniguchi N, Tanabe Y, et al. Oxidative imbalance in idiopathic renal hypouricemia. Pediatr Nephrol 2009; 24:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/79\">",
"      Sahlin K, Ekberg K, Cizinsky S. Changes in plasma hypoxanthine and free radical markers during exercise in man. Acta Physiol Scand 1991; 142:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/80\">",
"      Hellsten-Westing Y, Kaijser L, Ekblom B, Sj&ouml;din B. Exchange of purines in human liver and skeletal muscle with short-term exhaustive exercise. Am J Physiol 1994; 266:R81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/81\">",
"      Erley CM, Hirschberg RR, Hoefer W, Schaefer K. Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia. Klin Wochenschr 1989; 67:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/82\">",
"      Dinour D, Bahn A, Ganon L, et al. URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews. Nephrol Dial Transplant 2011; 26:2175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/83\">",
"      Sorensen CM, Chandhoke PS. Hyperuricosuric calcium nephrolithiasis. Endocrinol Metab Clin North Am 2002; 31:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/84\">",
"      Kaneko K, Yamanobe T, Onoda M, et al. Analysis of urinary calculi obtained from a patient with idiopathic hypouricemia using micro area x-ray diffractometry and LC-MS. Urol Res 2005; 33:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7177/abstract/85\">",
"      Nishizaki N, Fujinaga S, Hirano D, et al. Hereditary renal hypouricemia: a cause of calcium oxalate urolithiasis in a young female. Clin Nephrol 2012; 77:161.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2315 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-83.177.194.223-190351C039-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7177=[""].join("\n");
var outline_f7_0_7177=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10360291\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3188296\">",
"      DECREASED PRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3187616\">",
"      Inherited disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3188304\">",
"      Acquired disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13090614\">",
"      URIC ACID OXIDATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3188312\">",
"      INCREASED URINARY EXCRETION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Familial renal hypouricemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3188323\">",
"      Acquired disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Fanconi syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Volume expansion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Intracranial disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Acquired immunodeficiency syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11797806\">",
"      - Inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Acute kidney injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H559528\">",
"      Uric acid stone formation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10360291\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7726972\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/2315\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2315|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/24/33166\" title=\"figure 1\">",
"      Mechanisms for urate reabsorption by the proximal tubule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/40/23182\" title=\"figure 2\">",
"      Mechanisms for urate secretion by the proximal tubule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2315|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/11/17595\" title=\"table 1\">",
"      Drugs that cause uricosuria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8567?source=related_link\">",
"      Cerebral salt-wasting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/18/12584?source=related_link\">",
"      Cystinosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/49/42773?source=related_link\">",
"      Definition of acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/31/502?source=related_link\">",
"      Diuretic-induced hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=related_link\">",
"      Evaluation of the patient with hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25637?source=related_link\">",
"      Purine nucleoside phosphorylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19481?source=related_link\">",
"      Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27400?source=related_link\">",
"      Types of renal disease in multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/42/24230?source=related_link\">",
"      Uric acid balance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/62/3047?source=related_link\">",
"      Uric acid nephrolithiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=related_link\">",
"      Uric acid renal diseases",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_0_7178="Management of nocturnal enuresis in children";
var content_f7_0_7178=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of nocturnal enuresis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/0/7178/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7178/contributors\">",
"     Naiwen D Tu, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7178/contributors\">",
"     Laurence S Baskin, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/0/7178/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7178/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7178/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/0/7178/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/0/7178/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/0/7178/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary incontinence is a common problem in children, occurring in approximately 15 percent of five-year-old children. Most of these children have isolated nocturnal enuresis (monosymptomatic nocturnal enuresis).",
"   </p>",
"   <p>",
"    The management of monosymptomatic nocturnal enuresis in children will be presented here. An overview of the causes and evaluation of nocturnal enuresis and bowel and bladder dysfunction are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40281?source=see_link\">",
"       \"Etiology and evaluation of nocturnal enuresis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link\">",
"       \"Etiology and clinical features of bladder dysfunction in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/50/25384?source=see_link\">",
"       \"Evaluation and diagnosis of bladder dysfunction in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41785?source=see_link\">",
"       \"Management of bladder dysfunction in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282090817\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The International Children&rsquo;s Continence Society (ICCS) has developed standardized terminology for lower urinary tract function and malfunction in children [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/1\">",
"     1",
"    </a>",
"    ]. The terminology is summarized below and discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40281?source=see_link&amp;anchor=H540528631#H540528631\">",
"     \"Etiology and evaluation of nocturnal enuresis in children\", section on 'Terminology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H2#H2\">",
"     \"Etiology and clinical features of bladder dysfunction in children\", section on 'Definitions of symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <strong>",
"     Enuresis",
"    </strong>",
"    (synonymous with intermittent nocturnal incontinence) &ndash; Discrete episodes of urinary incontinence during sleep in children &ge;5 years of age.",
"   </p>",
"   <p>",
"    <strong>",
"     Monosymptomatic enuresis",
"    </strong>",
"    &ndash; Enuresis in children without any other lower urinary tract symptoms and without a history of bladder dysfunction; children who have never achieved a satisfactory period of nighttime dryness have primary enuresis; children who develop enuresis after a dry period of at least six months have secondary enuresis.",
"   </p>",
"   <p>",
"    Monosymptomatic enuresis is the focus of this topic review.",
"   </p>",
"   <p>",
"    <strong>",
"     Non-monosymptomatic enuresis &ndash;",
"    </strong>",
"    Enuresis in children with other lower urinary tract symptoms (eg, increased frequency, daytime incontinence, urgency, genital or lower urinary tract pain).",
"   </p>",
"   <p>",
"    Non-monosymptomatic enuresis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H6#H6\">",
"     \"Etiology and clinical features of bladder dysfunction in children\", section on 'Daytime urinary incontinence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282090869\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary monosymptomatic nocturnal enuresis has a high rate of spontaneous resolution (approximately 15 percent per year) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40281?source=see_link&amp;anchor=H2#H2\">",
"     \"Etiology and evaluation of nocturnal enuresis in children\", section on 'Epidemiology and natural history'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H110105409\">",
"    <span class=\"h1\">",
"     PRETREATMENT EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of children with enuresis is discussed separately. It is particularly important to look for causes of nocturnal enuresis that may require additional evaluation and treatment (eg, diabetes mellitus, obstructive sleep apnea, encopresis or constipation, bowel and bladder dysfunction, etc). It is difficult to successfully treat enuresis if coexistent constipation is not addressed. When evaluating for constipation, it may be helpful to ask about soiling in addition to the usual questions about bowel habits. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40281?source=see_link&amp;anchor=H12#H12\">",
"     \"Etiology and evaluation of nocturnal enuresis in children\", section on 'Differential diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28473?source=see_link&amp;anchor=H27172953#H27172953\">",
"     \"Sleepwalking and other parasomnias in children\", section on 'Sleep enuresis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=see_link\">",
"     \"Evaluation of suspected obstructive sleep apnea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602906566\">",
"    <span class=\"h1\">",
"     MANAGEMENT APPROACH",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602908273\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guidelines for the evaluation and management of nocturnal enuresis have been developed by the International Children&rsquo;s Continence Society (ICCS), the National Institute for Health and Clinical Excellence (NICE), and the Paediatric Society of New Zealand [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The recommendations in this topic review are based upon the recommendations of these groups.",
"   </p>",
"   <p>",
"    Management of primary nocturnal enuresis may involve one or a combination of interventions, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Education and reassurance (given the high rate of spontaneous resolution)",
"     </li>",
"     <li>",
"      Motivational therapy (eg, sticker or star chart)",
"     </li>",
"     <li>",
"      Enuresis alarms",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       Desmopressin",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The management of secondary nocturnal enuresis involves addressing the underlying stressor if one can be identified. However, most children with secondary enuresis have no identifiable cause and are treated in the same manner as children with primary enuresis. &nbsp;",
"   </p>",
"   <p>",
"    When the parents and child are interested and motivated to work toward long-term management, education and motivational therapies usually are tried initially (for three to six months). More active intervention (eg, enuresis alarm,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    ) is warranted as the child gets older, social pressures increase, and self-esteem is affected. Enuresis alarms are the most effective long-term therapy, but desmopressin is effective in the short-term (eg, for sleepovers or camp attendance).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602911006\">",
"    <span class=\"h3\">",
"     Goals of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of interventions for nocturnal enuresis include [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      To stay dry on particular occasions (eg, sleepover)",
"     </li>",
"     <li>",
"      To reduce the number of wet nights",
"     </li>",
"     <li>",
"      To reduce the impact of enuresis on the child and family",
"     </li>",
"     <li>",
"      To avoid recurrence",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602908662\">",
"    <span class=\"h3\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before beginning therapy, the pediatric healthcare provider should define the expectations of the parents and child. Some parents may simply want assurance that the enuresis is not caused by a physical abnormality and are not interested in initiating a long-term treatment program. It is also important to determine whether short-term dryness is a priority (eg, so the child can attend camp or go on a school trip) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pediatric healthcare providers should emphasize that bedwetting is not the child&rsquo;s fault and that the child should not be punished for bedwetting [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Surveys indicate that between one-fourth and one-third of parents punish their child for wetting the bed, and sometimes the punishment is physically abusive [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Child abuse should be considered if the child is reported to be deliberately wetting the bed [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. Parents or caregivers who are having difficulty coping with bedwetting or are expressing anger, negativity, or blame toward the child may need additional support [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pediatric healthcare provider should stress to the parents and child that a carefully constructed enuresis treatment program often involves several methods of treatment, used in sequence or combination. The treatment may be prolonged, may fail in the short term, and often is associated with relapses. The parents must be willing to participate, and the family environment must be supportive. Therapy should be goal-oriented, and follow-up should be consistent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Comorbid constipation should be addressed in conjunction with nocturnal enuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/41/2710?source=see_link&amp;anchor=H6#H6\">",
"     \"Prevention and treatment of acute constipation in infants and children\", section on 'Acute constipation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/28/36298?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment of chronic functional constipation and fecal incontinence in infants and children\", section on 'Treatment of children'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602908167\">",
"    <span class=\"h3\">",
"     When to initiate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The timing of initiation of treatment for monosymptomatic nocturnal enuresis varies from child to child. The major determinants are whether the child and caregivers view the enuresis as a problem and how strongly motivated they are to participate in a treatment program.",
"   </p>",
"   <p>",
"    The age at which enuresis is considered to be a \"problem\" varies depending upon the family. If both parents wet the bed until late childhood, they may not be concerned that their seven-year-old wets the bed. In contrast, parents may be concerned about a four-year-old who wets if he has a three-year-old sibling who is already dry. For the child, nocturnal enuresis usually becomes significant when it interferes with his or her ability to socialize with peers [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to determine whether the child is mature enough to assume responsibility for treatment. Treatment probably should be delayed if it seems that the parents are more interested in treatment than the child and the child is unwilling or unable to assume some responsibility for the treatment program. The child must be highly motivated to participate in a treatment program that may take months to achieve successful results.",
"   </p>",
"   <p>",
"    Children younger than seven years usually can be managed with education and motivational therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ]. However, age should not be the only criterion for initiation of active treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. Enuresis as infrequent as once per month is associated with decreased self-esteem; decreased self-esteem can be improved with treatment, even if the treatment is not completely successful [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H60381896\">",
"    <span class=\"h3\">",
"     Indications for referral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monosymptomatic nocturnal enuresis usually can be managed effectively by the primary care provider. However, children with refractory or nightly nocturnal enuresis may benefit from referral to a healthcare professional who specializes in the management of recurrent or refractory enuresis (eg, developmental-behavioral pediatrician or urologist if structural or anatomic abnormalities are suspected) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Additional indications for referral include non-monosymptomatic enuresis; developmental, attentional, or learning difficulties; behavioral or emotional problems; and known or suspected physical or neurologic problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602906573\">",
"    <span class=\"h2\">",
"     Initial management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial management of enuresis usually involves education and motivational therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602906787\">",
"    <span class=\"h3\">",
"     Education and advice",
"    </span>",
"    &nbsp;&mdash;&nbsp;The guidelines of the International Children&rsquo;s Continence Society, National Institute for Health and Clinical Excellence, and Paediatric Society of New Zealand recommend the provision of basic",
"    <span class=\"nowrap\">",
"     education/advice",
"    </span>",
"    for children and caregivers of children with nocturnal enuresis as the initial step in management [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The education and advice typically includes the following information:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enuresis is common; it occurs at least once per week in 16 percent of five-year-olds; enuresis resolves on its own in the majority of children (",
"      <a class=\"graphic graphic_figure graphicRef58087 \" href=\"UTD.htm?39/7/40061\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40281?source=see_link&amp;anchor=H2#H2\">",
"       \"Etiology and evaluation of nocturnal enuresis in children\", section on 'Epidemiology and natural history'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Enuresis is the fault of neither the child nor the caregivers; children should not be punished for bedwetting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40281?source=see_link&amp;anchor=H4#H4\">",
"       \"Etiology and evaluation of nocturnal enuresis in children\", section on 'Causes'",
"      </a>",
"      .).",
"     </li>",
"     <li>",
"      The impact of bedwetting can be reduced by using bed protection and",
"      <span class=\"nowrap\">",
"       washable/disposable",
"      </span>",
"      products; using room deodorizers; thoroughly washing the child before dressing; and using emollients to prevent chafing.",
"     </li>",
"     <li>",
"      Keeping a calendar of wet and dry nights helps to determine the effect of interventions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40281?source=see_link&amp;anchor=H704514100#H704514100\">",
"       \"Etiology and evaluation of nocturnal enuresis in children\", section on 'Voiding diary'",
"      </a>",
"      .).",
"     </li>",
"     <li>",
"      The child should attempt to void regularly during the day and just before going to bed (a total of four to seven times); if the child wakes at night, the caregivers should take",
"      <span class=\"nowrap\">",
"       him/her",
"      </span>",
"      to the toilet.",
"     </li>",
"     <li>",
"      High-sugar and caffeine-based drinks should be avoided in children with enuresis, particularly in the evening hours.",
"     </li>",
"     <li>",
"      Daily fluid intake should be concentrated in the morning and early afternoon; fluid and solute intake should be minimized during the evening. Some authors recommend that their enuretic patients drink 40 percent of their total daily fluid in the morning (7 a.m. to 12 p.m.), 40 percent in the afternoon (12 p.m. to 5 p.m.), and only 20 percent in the evening (after 5 p.m.) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/9\">",
"       9",
"      </a>",
"      ]. Ample consumption of fluid in the morning and afternoon reduces the need for significant intake later in the day. Isolated nighttime fluid restriction, without compensatory increase in daytime fluid consumption, may prevent the child from meeting his or her daily fluid requirement and is usually unsuccessful. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/20/6470?source=see_link&amp;anchor=H2#H2\">",
"       \"Maintenance fluid therapy in children\", section on 'Maintenance water needs'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The routine use of diapers and pull-ups can interfere with motivation for getting up at night and is generally discouraged (exceptions can be made when the child is sleeping away from home) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602907926\">",
"    <span class=\"h3\">",
"     Motivational therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the child agrees to accept some responsibility for the treatment program, he or she can be motivated by keeping a record of progress. Initial rewards should be given for agreed-upon behavior (eg, going to the toilet before bedtime) rather than dryness [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. Successively larger rewards, agreed upon in advance, are given for longer compliance with agreed-upon behavior and, eventually, for longer periods of dryness (eg, a sticker on a calendar for each dry night, a book for seven consecutive dry nights). Penalties (ie, removal of previously gained rewards) are counterproductive [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Motivational therapy is a good first-line therapy for nocturnal enuresis in younger children (between five and seven years of age) who do not wet the bed every night [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5,12,17\">",
"     5,12,17",
"    </a>",
"    ]. Motivational therapy is estimated to be successful (14 consecutive dry nights) in 25 percent of children and to lead to significant improvement (decrease in enuretic events by &ge;80 percent) in more than 70 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The relapse rate (more than two wet nights in two weeks) is approximately 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/20\">",
"     20",
"    </a>",
"    ]. In a systematic review of simple behavioral interventions for nocturnal enuresis, reward systems (eg, star charts) were associated with fewer wet nights, higher cure rates, and lower relapse rates than no treatment, but these results were based on single small trials [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If motivational therapy fails to lead to improvement after three to six months, the addition of active interventions may be warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602906580\">",
"    <span class=\"h2\">",
"     Addition of active therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enuresis alarms and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    are effective active therapies for nocturnal enuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,21,22\">",
"     4,21,22",
"    </a>",
"    ]. Each has advantages and disadvantages. The best active intervention for a particular child depends upon how soon a response is desired, the motivation and commitment of the child and family, and the frequency and volume of enuresis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602907166\">",
"    <span class=\"h3\">",
"     Enuresis alarms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enuresis alarms are activated when a sensor, placed in the undergarments or on a bed pad, detects moisture; the arousal devise is usually an auditory alarm",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a vibrating belt or pager (",
"    <a class=\"graphic graphic_figure graphicRef66340 \" href=\"UTD.htm?38/52/39747\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef61732 \" href=\"UTD.htm?40/26/41388\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/9,12\">",
"     9,12",
"    </a>",
"    ]. The type of alarm should be tailored to the child&rsquo;s needs and abilities. The alarms work through conditioning: the child learns to wake or inhibit bladder contraction in response to the physiologic conditions present before wetting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94390359\">",
"    <span class=\"h4\">",
"     Indications and contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enuresis alarms are a first-line treatment for children whose bedwetting has not responded to advice about fluid intake, toileting, or an appropriate reward system [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ]. Enuresis alarms work best for well-motivated families and children with frequent enuresis (more than twice per week) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. They may be used in children younger than seven years, depending upon the child&rsquo;s ability, motivation, and understanding of the alarm. The child must be able to wake to sound or touch for the alarm to work; it is helpful to test this ability before the enuresis alarm is prescribed or purchased [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other treatment options should be used if [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rapid or short-term improvement is the goal",
"     </li>",
"     <li>",
"      The child or parents do not want to try the enuresis alarm",
"     </li>",
"     <li>",
"      The child wets the bed only once or twice per week",
"     </li>",
"     <li>",
"      The parents are having emotional difficulty coping with the burden of bedwetting",
"     </li>",
"     <li>",
"      The parents are expressing anger, negativity, or blame toward the child",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94390366\">",
"    <span class=\"h4\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enuresis alarms are the most effective means of controlling nocturnal enuresis and preventing relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/21,23-25\">",
"     21,23-25",
"    </a>",
"    ]. In a meta-analysis of 56 randomized trials (3257 children), the following results were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/21\">",
"     21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sixty-six percent of children became dry for 14 consecutive nights during alarm use versus only 4 percent of no-treatment controls (relative risk [RR] for treatment failure 0.38, 95% CI 0.33-0.45).",
"     </li>",
"     <li>",
"      Nearly one-half of children who continued to use the alarm remained dry after treatment, compared with almost none in the no-treatment group (45 versus 1 percent, RR for relapse 0.56, 95% CI 0.46-0.68).",
"     </li>",
"     <li>",
"      During the first week of treatment, children had fewer wet nights with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       desmopressin",
"      </a>",
"      than alarms (weighted mean difference 2.1, 95% CI 0.99-3.21); toward the end of treatment, they had fewer wet nights with alarms, but this result was not statistically significant.",
"     </li>",
"     <li>",
"      Alarms were more effective than tricyclic antidepressants during and after treatment. Treatment with tricyclic antidepressants is discussed below. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Tricyclic antidepressants'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94390373\">",
"    <span class=\"h4\">",
"     Instructions and adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The family should be instructed that the child is in charge of the alarm [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/26\">",
"     26",
"    </a>",
"    ]. Each night before he or she goes to sleep, the child should test the alarm; with the sound (or vibration) in mind, the child should imagine in detail, for one to two minutes, the sequence of events that occur when the alarm sounds (or vibrates) during sleep. The sequence is as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,5,26\">",
"     4,5,26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The child turns off the alarm, gets up, and finishes voiding in the toilet (only the child should turn off the alarm). At the initiation of therapy, the child may occasionally fail to awaken; this can be ameliorated if the parents wake the child when the alarm sounds. The child&rsquo;s being fully awake and cognizant of what is happening is critical to the success of alarm therapy.",
"     </li>",
"     <li>",
"      The child returns to the bedroom.",
"     </li>",
"     <li>",
"      The child changes the bedding and underwear.",
"     </li>",
"     <li>",
"      The child wipes down the sensor with a wet cloth and then a dry cloth (or replaces the sensor if it is disposable)",
"     </li>",
"     <li>",
"      The child resets the alarm and returns to sleep.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Changes of linen and clothing should be kept near the bed. The parents may need to help the child wake to the alarm and should supervise the changing of bed linens. A diary should be kept of wet and dry nights. Positive reinforcement should be provided for dry nights as well as successful completion of the above sequence of events. Penalties (eg, the removal of a reward) for wetting episodes appear to be counterproductive [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H602907926\">",
"     'Motivational therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Approximately 30 percent of patients discontinue enuresis alarms for various reasons, including skin irritation, disturbance of other family members,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    failure to wake the child [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/8,27,28\">",
"     8,27,28",
"    </a>",
"    ]. Adverse effects of alarms include alarm failure, false alarms, failure to wake the child, disruption of other family members, and lack of adherence because of difficulty using the alarm [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94390380\">",
"    <span class=\"h4\">",
"     Monitoring response",
"    </span>",
"    &nbsp;&mdash;&nbsp;The child should be seen in follow-up (or have telephone follow-up) within one to two weeks of initiating alarm therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5,8\">",
"     5,8",
"    </a>",
"    ]. Treatment should be continued if the child demonstrates early signs of response (eg, smaller wet patches; waking to the alarm; alarm going off later in the night; fewer alarms per night; fewer wet nights).",
"   </p>",
"   <p>",
"    Alarm treatment should be continued until the child has had a minimum of 14 consecutive dry nights [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5,20\">",
"     5,20",
"    </a>",
"    ]. This usually takes between 12 and 16 weeks, with a range of 5 to 24 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/20\">",
"     20",
"    </a>",
"    ]. If, after three months of alarm therapy, the child has not achieved complete dryness (14 consecutive nights), but has fewer wet nights, alarm therapy should be continued [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. Alternative interventions may be warranted if there has been no improvement after three months of alarm therapy. (See",
"    <a class=\"local\" href=\"#H602906587\">",
"     'Refractory enuresis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Therapy with the alarm can be reinitiated for relapse (more than two wet nights in two weeks). Children who relapse after discontinuation of the alarm usually can achieve a rapid secondary response due to preconditioning as a result of the first treatment program. (See",
"    <a class=\"local\" href=\"#H602906587\">",
"     'Refractory enuresis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602907610\">",
"    <span class=\"h3\">",
"     Desmopressin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     Desmopressin",
"    </a>",
"    (a synthetic vasopressin analog) is a first-line treatment for enuresis in children older than five years whose bedwetting has not responded to advice about fluid intake, toileting, or an appropriate reward system [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. It is an alternative to enuresis alarms for children and families who seek rapid or short-term improvement of enuresis; have failed, refused, or are unlikely to adhere to enuresis alarm treatment; and for whom an enuresis alarm is unsuitable. (See",
"    <a class=\"local\" href=\"#H602907166\">",
"     'Enuresis alarms'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94390395\">",
"    <span class=\"h4\">",
"     Indications/contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     Desmopressin",
"    </a>",
"    works best for children with nocturnal polyuria and normal functional bladder capacity [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,29\">",
"     4,29",
"    </a>",
"    ]. Nocturnal polyuria is defined by nocturnal urine production greater than 130 percent of expected bladder capacity for age [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ]. By convention, expected bladder capacity (in mL) is estimated with the following formula: 30 x (age [in years] +1) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/1\">",
"     1",
"    </a>",
"    ]. Compared with other modes of therapy, desmopressin is relatively expensive [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/12\">",
"     12",
"    </a>",
"    ]. Desmopressin should not be used in children with hyponatremia or a history of hyponatremia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94390402\">",
"    <span class=\"h4\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 30 percent of patients achieve total dryness using",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    , with perhaps another 40 percent exhibiting a significant decrease in nighttime wetting [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ]. However, the relapse rate after discontinuation is high (60 to 70 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/23\">",
"     23",
"    </a>",
"    ]. In a systematic review of 41 randomized trials (2760 children) comparing desmopressin to other drugs or alarms in the treatment of nocturnal enuresis, the following findings were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Compared with placebo,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       desmopressin",
"      </a>",
"      reduced bedwetting by 1.34 nights per week (95% CI 1.11-1.57).",
"     </li>",
"     <li>",
"      Compared with placebo, children treated with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       desmopressin",
"      </a>",
"      were more likely to become dry (ie, no episodes for 14 nights) (81 versus 98 percent, RR for failure 0.84, 95% CI 0.79-0.91)",
"     </li>",
"     <li>",
"      In contrast to arousal alarms, treatment effects were not sustained after discontinuation of therapy (the rate of failure or relapse was 65 and 46 percent with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       desmopressin",
"      </a>",
"      and alarms, respectively; relative risk of failure 1.42, 95% CI 1.05-1.91)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       Desmopressin",
"      </a>",
"      and tricyclic antidepressants appear to be equally effective.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94390409\">",
"    <span class=\"h4\">",
"     Administration and adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     Desmopressin",
"    </a>",
"    is administered in the late evening to reduce urine production during sleep. It is given orally (the intranasal formulation was associated with increased risk of hyponatremic seizures and is no longer indicated for the treatment of enuresis) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/30\">",
"     30",
"    </a>",
"    ]. The dose is titrated to best effect. The anti-enuretic effect is seen immediately once the correct dose is achieved [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The dose and timing of administration depend upon the formulation. Regular tablets (the only formulation available in the United States) are given one hour before bedtime [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,14\">",
"     4,14",
"    </a>",
"    ]. The initial dose is 0.2 mg (one tablet); if needed after 10 to 14 days, the dose may be increased by 0.2 mg to a maximum dose of 0.4 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ]. Oral melt tablets are given 30 to 60 minutes before bedtime. The initial dose is 120 mcg; if needed after 10 to 14 days, the dose may be increased by 120 mcg to a maximum dose of 240 mcg [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A \"trial run\" of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    is recommended if the child plans to use it for overnight camp. The trial should take place at least six weeks before camp in order to adequately titrate the dose and make sure that it will be effective.",
"   </p>",
"   <p>",
"    Adverse effects of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    therapy are uncommon. The most serious adverse effect is dilutional hyponatremia, which occurs when excess fluids are taken in the evening hours [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. To prevent dilutional hyponatremia with oral desmopressin, it is recommended that fluid intake be limited to eight ounces (240 mL) from one hour before to eight hours after administration of desmopressin [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/22\">",
"     22",
"    </a>",
"    ]. Treatment with desmopressin should be interrupted during episodes of fluid",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    electrolyte imbalance (eg, fever, recurrent vomiting or diarrhea, vigorous exercise, or other conditions associated with increased water consumption) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/30\">",
"     30",
"    </a>",
"    ]. It is not necessary to routinely measure weight, serum electrolytes, blood pressure, or urine osmolality in children being treated with desmopressin for bedwetting [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H94390416\">",
"    <span class=\"h4\">",
"     Assessing response",
"    </span>",
"    &nbsp;&mdash;&nbsp;The response to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    should be assessed within one to two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/8\">",
"     8",
"    </a>",
"    ]. Treatment should be continued for three months if there are signs of a response (eg, smaller wet patches, fewer wetting episodes per night, fewer wet nights) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. If enuresis improves or remits with desmopressin, the family and child can determine whether to use desmopressin every night or just for special occasions (eg, sleepovers). When it is administered daily, desmopressin should be withheld for one week every three months to determine whether continued use is necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lack of response to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    may be due to reduced nocturnal bladder capacity (the most common reason for unresponsiveness) or persistent nocturnal polyuria (related to increased fluid intake in the evening, increased nocturnal solute excretion, or reduced pharmacodynamic effect of desmopressin) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/14,29,34\">",
"     14,29,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H60385546\">",
"    <span class=\"h2\">",
"     Treatment of relapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;Relapse is defined by more than one wet night per month after a period of dryness [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/1\">",
"     1",
"    </a>",
"    ]. Treatment of relapse varies depending upon the initial management.",
"   </p>",
"   <p>",
"    The initial response is to reinitiate whatever intervention was effective in the past [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5,8\">",
"     5,8",
"    </a>",
"    ]. For children with multiple recurrences after discontinuation of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    , it may be helpful to try tapering desmopressin gradually, rather than stopping it suddenly [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H602907166\">",
"     'Enuresis alarms'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H602907610\">",
"     'Desmopressin'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Combination alarm and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    therapy may be beneficial for children who have more than one recurrence following successful treatment with an alarm. In a meta-analysis, children treated with combination desmopressin and alarm therapy had fewer wet nights than children treated with alarms alone (weighted mean difference -0.83, 95% CI -1.11 to -0.55) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/22\">",
"     22",
"    </a>",
"    ]. However, failure and relapse rates did not differ.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602906587\">",
"    <span class=\"h2\">",
"     Refractory enuresis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonresponse to active intervention is defined by &lt;50 percent improvement in symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/1\">",
"     1",
"    </a>",
"    ]. When motivated children and families do not respond to an adequate trial of treatment with an enuresis alarm (ie, three months)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    (at a dose of 0.4 mg), referral to a healthcare professional who specializes in the management of bedwetting that has not responded to initial treatment (eg, developmental-behavioral pediatrician, pediatric urologist) may be warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Possible reasons for lack of response include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overactive bladder (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H7#H7\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Overactive bladder'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Underlying disease (eg, diabetes mellitus)",
"     </li>",
"     <li>",
"      Incorrect use of alarm (see",
"      <a class=\"local\" href=\"#H602907166\">",
"       'Enuresis alarms'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Occult constipation (it may be helpful to ask about soiling in addition to the usual questions about bowel habits)",
"     </li>",
"     <li>",
"      Sleep apnea (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=see_link&amp;anchor=H20#H20\">",
"       \"Evaluation of suspected obstructive sleep apnea in children\", section on 'Diagnostic criteria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Social and emotional factors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional evaluation of such children may include [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Abdominal/pelvic",
"      </span>",
"      ultrasonography (increased bladder-wall thickness may indicate bladder overactivity; rectal distension may be a sign of occult constipation) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/50/25384?source=see_link&amp;anchor=H13#H13\">",
"       \"Evaluation and diagnosis of bladder dysfunction in children\", section on 'Ultrasonography'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Completion of a frequency volume chart if one was not completed previously",
"     </li>",
"     <li>",
"      Rectal examination, anorectal manometry, or abdominal radiographs to look for occult constipation [",
"      <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/36,37\">",
"       36,37",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Following additional evaluation to exclude other causes of enuresis, management of therapy-resistant monosymptomatic nocturnal enuresis may include [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4,5,24,38\">",
"     4,5,24,38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Periodic new trials of the enuresis alarm (with or without the addition of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       desmopressin",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H602907166\">",
"       'Enuresis alarms'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       Desmopressin",
"      </a>",
"      alone if continued use of the alarm is no longer acceptable to the child or parents or if there was a partial response to combination treatment with desmopressin and an alarm after initial treatment with an alarm (see",
"      <a class=\"local\" href=\"#H602907610\">",
"       'Desmopressin'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      A trial of a tricyclic antidepressant",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Tricyclic antidepressants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tricyclic antidepressants (TCAs) decrease the amount of time spent in REM sleep, stimulate vasopressin secretion, and relax the detrusor muscle. Given the efficacy and safety of enuresis alarms and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    , tricyclic antidepressants (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/5/31831?source=see_link\">",
"     imipramine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/32/7687?source=see_link\">",
"     amitriptyline",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?35/16/36103?source=see_link\">",
"     desipramine",
"    </a>",
"    ) are a third-line treatment for monosymptomatic enuresis (eg, children who have failed alarm therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    desmopressin) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ]. When used to treat enuresis, tricyclic antidepressants usually are prescribed by healthcare providers who specialize in the management of bedwetting that has not responded to initial treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a systematic review, compared with placebo, treatment with tricyclic or related drugs was associated with a reduction of approximately one wet night per week [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/39\">",
"     39",
"    </a>",
"    ]. Approximately 20 percent of children became dry (14 consecutive nights) during therapy (versus 5 percent with placebo, relative risk for failure 0.77, 95% CI 0.72-0.83). The rate of relapse was 96 percent after discontinuation of therapy. TCAs and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    were similarly effective during therapy.",
"   </p>",
"   <p>",
"    Although other TCAs are effective,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/5/31831?source=see_link\">",
"     imipramine",
"    </a>",
"    is used most often in the treatment of enuresis. It is the only TCA recommended by the National Institute for Health and Clinical Excellence guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. Imipramine should be administered one hour before bedtime [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/8\">",
"     8",
"    </a>",
"    ]. Imipramine is supplied in 10 mg, 25 mg, and 50 mg tablets. The initial dose is 10 to 25 mg at bedtime and may be increased by 25 mg if there is no response after one week. On average, the bedtime dose is 25 mg for children five to eight years of age and 50 mg for older children. The dose should not exceed 50 mg in children between 6 and 12 years of age and 75 mg in children &ge;12 years of age.",
"   </p>",
"   <p>",
"    The response to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/5/31831?source=see_link\">",
"     imipramine",
"    </a>",
"    should be assessed after one month. If there is no improvement after three months, it should be discontinued; imipramine should be discontinued gradually [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. If imipramine therapy is successful, the family should taper to the lowest effective dose. Approximately every three months, imipramine should be discontinued for at least two weeks to decrease the risk of tolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A \"trial run\" of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/5/31831?source=see_link\">",
"     imipramine",
"    </a>",
"    is recommended if the child plans to use it for overnight camp. The trial should take place at least six weeks before camp in order to titrate the dose adequately and make sure that it will be effective.",
"   </p>",
"   <p>",
"    Adverse effects of TCA therapy are relatively uncommon. Approximately 5 percent of children treated with TCAs develop neurologic symptoms, including nervousness, personality change, and disordered sleep.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/5/31831?source=see_link\">",
"     Imipramine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/32/7687?source=see_link\">",
"     amitriptyline",
"    </a>",
"    , and other TCAs are required by the United States Food and Drug Administration to carry a black box warning regarding the possibility of increased suicidality, particularly in individuals with preexisting depressive symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/23/15736?source=see_link&amp;anchor=H9#H9\">",
"     \"Effect of antidepressants on suicide risk in children and adolescents\", section on 'FDA black box warning'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most serious adverse effects of TCAs involve the cardiovascular system: cardiac conduction disturbances and myocardial depression, particularly in cases of overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/20\">",
"     20",
"    </a>",
"    ]. Before initiation of therapy with TCA, a thorough cardiac history and family cardiac history should be obtained. A family history of a first-degree relative with premature (&lt;40 years of age) cardiac problems or a personal history of cardiac disease warrants a consultation with a pediatric cardiologist before starting a TCA [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/41\">",
"     41",
"    </a>",
"    ]. The pretreatment evaluation also should include a complete history and physical examination, with particular attention to weight, blood pressure and pulse rate, and a baseline electrocardiogram (EKG) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/41\">",
"     41",
"    </a>",
"    ]. TCA therapy should not be initiated unless these parameters are within the normal limits for the child's age, sex, and height. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36231?source=see_link&amp;anchor=H3#H3\">",
"     \"Tricyclic antidepressant poisoning\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602906192\">",
"    <span class=\"h1\">",
"     OTHER INTERVENTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other interventions have been used for nocturnal enuresis or refractory nocturnal enuresis. These include waking the child to urinate, bladder training exercises, anticholinergic and other drugs, and complementary and alternative therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602906273\">",
"    <span class=\"h2\">",
"     Waking the child to urinate",
"    </span>",
"    &nbsp;&mdash;&nbsp;These interventions involve waking the child to use the bathroom after he or she has fallen asleep. Older children may use an alarm clock to wake themselves. Critics of these interventions suggest that they may keep the bed dry but do not teach the child to wake to the sensation of a full bladder [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/42\">",
"     42",
"    </a>",
"    ]. Nonetheless, in single, small trials, waking the child to urinate has been associated with fewer wet nights, higher cure rates, and lower relapse rates than no treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/17,42\">",
"     17,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We do not suggest waking the child to urinate. The International Children&rsquo;s Continence Society guidelines indicate that, &ldquo;If the parents have a habit of waking the child at night to go to the toilet, they should be informed that it is allowed but not needed and would only help for that specific night, if at all&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"     4",
"    </a>",
"    ]. The National Institute for Health and Clinical Excellence guidelines suggest that waking the child may be used as a practical measure in the short-term management of bedwetting (to reduce the burden of clean-up) but does not promote long-term dryness [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. Other authors suggest that these interventions may be helpful for young children (eg, four to five years of age) who wet the bed only once per night and have motivated parents [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Waking also may be helpful for children &ge;8 years who have not responded to initial treatments and choose parental waking over enuresis alarms or an alarm clock [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602906280\">",
"    <span class=\"h3\">",
"     Alarm clocks",
"    </span>",
"    &nbsp;&mdash;&nbsp;It may be possible to condition older children to wake to void by using an alarm clock (or mobile phone alarm) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/45\">",
"     45",
"    </a>",
"    ]. In one study, 125 children (7 to 21 years of age) with primary nocturnal enuresis were enrolled in two treatment groups and treated for four months [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/45\">",
"     45",
"    </a>",
"    ]. Group I children were awakened to void when the bladder was full, but they remained dry (the waking time was determined individually during a one- to three-week trial period); Group II children were awakened after two to three hours of sleep (whether they were wet or dry). One-third of the patients stopped using the alarm within one month. Among those who continued, initial success (14 consecutive dry nights) was obtained in both groups (77 percent in group I and 62 percent in group II). The relapse rate six months after stopping therapy was 24 percent for group I and 15 percent for group II. The authors concluded that an ordinary alarm clock is a safe, effective, noncontact treatment strategy for enuresis that does not require an episode of bedwetting to initiate a conditioning response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H602906396\">",
"    <span class=\"h2\">",
"     Bladder training",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder training, also known as retention control training, involves asking the child to hold his or her urine for successively longer intervals to increase bladder capacity. Bladder training is a common component of multimodal therapy programs. We do not recommend bladder training in the initial management of monosymptomatic nocturnal enuresis.",
"   </p>",
"   <p>",
"    In randomized trials, bladder training exercises increased bladder capacity [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. However, increased bladder capacity was not associated with improved enuresis or improved response rate to subsequent treatment with an enuresis alarm [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. A systematic review of simple behavioral and physical interventions for nocturnal enuresis in children found insufficient evidence to evaluate bladder training in isolation or in combination with other interventions [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The National Institute for Health and Clinical Excellence guidelines recommend against strategies that promote the interruption of urinary stream or encourage infrequent passing of urine during the day [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/5\">",
"     5",
"    </a>",
"    ]. The Paediatric Society of New Zealand guidelines recommend against bladder training as an initial treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/6,17\">",
"     6,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Anticholinergic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monotherapy with anticholinergic drugs, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/11/40117?source=see_link\">",
"     oxybutynin",
"    </a>",
"    , is not effective in treating monosymptomatic nocturnal enuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. However, anticholinergic agents may be useful in children with nocturnal enuresis and daytime incontinence. In such children, anticholinergic therapy may be used in combination with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    to increase bladder capacity during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/50-54\">",
"     50-54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/50/25384?source=see_link&amp;anchor=H3#H3\">",
"     \"Evaluation and diagnosis of bladder dysfunction in children\", section on 'When to suspect bladder dysfunction'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41785?source=see_link\">",
"     \"Management of bladder dysfunction in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41785?source=see_link&amp;anchor=H9#H9\">",
"     \"Management of bladder dysfunction in children\", section on 'Pharmacologic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Other drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other drugs, including",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/27/17848?source=see_link\">",
"     indomethacin",
"    </a>",
"    , phenmetrazine, amphetamine sulfate, ephedrine,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/13/25816?source=see_link\">",
"     atropine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/26/5544?source=see_link\">",
"     furosemide",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/59/37808?source=see_link\">",
"     diclofenac",
"    </a>",
"    , and chlorprothixene have been tried in the treatment of nocturnal enuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/55\">",
"     55",
"    </a>",
"    ]. A 2012 systematic review of randomized trials of drugs other than tricyclic antidepressants and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    found that although indomethacin, diclofenac, and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/34/32296?source=see_link\">",
"     diazepam",
"    </a>",
"    were better than placebo in reducing the number of wet nights, none of the drugs was better than desmopressin [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Complementary and alternative therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;A review of complementary approaches such as hypnosis, psychotherapy, and acupuncture found limited evidence from small trials with methodologic limitations to support the use of such modalities for the treatment of nocturnal enuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/0/7178/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/39/37489?source=see_link\">",
"       \"Patient information: Bedwetting in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/9/7315?source=see_link\">",
"       \"Patient information: Bedwetting in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary monosymptomatic enuresis (ie, bedwetting) is defined by discrete episodes of urinary incontinence during sleep in children &ge;5 years of age who have never achieved a satisfactory period of nighttime dryness, have no lower urinary tract symptoms, and have no history of bladder dysfunction. (See",
"      <a class=\"local\" href=\"#H282090817\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary monosymptomatic enuresis has a high rate of spontaneous resolution (approximately 15 percent per year). (See",
"      <a class=\"local\" href=\"#H282090869\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management of primary nocturnal enuresis may involve one or a combination of interventions. Education and motivational therapies usually are tried initially. More active intervention is warranted as the child gets older, social pressures increase, and self-esteem is affected. (See",
"      <a class=\"local\" href=\"#H602908273\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      General education and advice about bedwetting should be provided to all children and families of children with monosymptomatic enuresis. It is important to emphasize that enuresis is not the child&rsquo;s fault; provide practical suggestions to reduce the impact of bedwetting; encourage regular voiding during the day and just before going to bed; and provide guidelines about the timing and type of fluid intake. (See",
"      <a class=\"local\" href=\"#H602906787\">",
"       'Education and advice'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Motivational therapy (eg, a star chart) is usually the first intervention for younger children (between five and seven years) who do not wet the bed every night and are mature enough to accept some responsibility for treatment. If motivational therapy fails to lead to improvement after three to six months, active interventions may be warranted. (See",
"      <a class=\"local\" href=\"#H602907926\">",
"       'Motivational therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Enuresis alarms (",
"      <a class=\"graphic graphic_figure graphicRef66340 \" href=\"UTD.htm?38/52/39747\">",
"       figure 2",
"      </a>",
"      ) and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       desmopressin",
"      </a>",
"      are effective interventions for nocturnal enuresis in children and families who desire active treatment. The choice of intervention for a particular child depends upon how soon a response is desired, the motivation and commitment of the child and family, and the frequency and volume of enuresis. (See",
"      <a class=\"local\" href=\"#H602906580\">",
"       'Addition of active therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Enuresis alarms are the most effective long-term therapy and have few adverse effects. However, they require a long-term commitment (usually three to four months). We suggest an enuresis alarm as the initial active therapy for highly motivated children and families when the child has frequent enuresis (more than twice per week) and short-term improvement is not a priority (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H602907166\">",
"       'Enuresis alarms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Oral",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       desmopressin",
"      </a>",
"      works best for children with nocturnal polyuria and normal functional bladder capacity. It may be more effective than an enuresis alarm in the short-term, but has a higher relapse rate and is more expensive. We suggest desmopressin as the initial active therapy for children and families who seek short-term improvement of enuresis; have failed, refused, or are unlikely to adhere to alarm therapy; or for whom an enuresis alarm is unsuitable (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H602907610\">",
"       'Desmopressin'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When motivated children and families do not respond to an adequate trial of treatment with an enuresis alarm",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/45/15062?source=see_link\">",
"       desmopressin",
"      </a>",
"      , referral to a healthcare professional who specializes in the management of bedwetting may be warranted. (See",
"      <a class=\"local\" href=\"#H602906587\">",
"       'Refractory enuresis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of relapse varies depending upon the initial management. The initial response is to reinitiate whatever intervention was effective in the past. (See",
"      <a class=\"local\" href=\"#H60385546\">",
"       'Treatment of relapse'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6534487\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Edmond Gonzales, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/1\">",
"      Nev&eacute;us T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol 2006; 176:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/2\">",
"      Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Study of 1129 enuretis. Arch Dis Child 1974; 49:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/3\">",
"      Klackenberg G. Nocturnal enuresis in a longitudinal perspective. A primary problem of maturity and/or a secondary environmental reaction? Acta Paediatr Scand 1981; 70:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/4\">",
"      Neveus T, Eggert P, Evans J, et al. Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International Children's Continence Society. J Urol 2010; 183:441.",
"     </a>",
"    </li>",
"    <li>",
"     National Institute for Health and Clinical Excellence. Nocturnal enuresis - the management of bedwetting in children and young people. file://www.nice.org.uk/guidance/index.jsp?action=download&amp;o=51367 (Accessed on February 28, 2011).",
"    </li>",
"    <li>",
"     Paediatric Society New Zealand. Noctural Enuresis \"Bedwetting,\" 2005. file://www.paediatrics.org.nz/files/guidelines/Enuresisguidelinefinalendorsed.pdf (Accessed on March 03, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/7\">",
"      Kiddoo D. Nocturnal enuresis. Clin Evid (Online) 2007; 2007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/8\">",
"      Schmitt BD. Nocturnal enuresis. Pediatr Rev 1997; 18:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/9\">",
"      Jalkut MW, Lerman SE, Churchill BM. Enuresis. Pediatr Clin North Am 2001; 48:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/10\">",
"      Shelov SP, Gundy J, Weiss JC, et al. Enuresis: a contrast of attitudes of parents and physicians. Pediatrics 1981; 67:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/11\">",
"      Schmitt BD. Seven deadly sins of childhood: advising parents about difficult developmental phases. Child Abuse Negl 1987; 11:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/12\">",
"      Cendron M. Primary nocturnal enuresis: current. Am Fam Physician 1999; 59:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/13\">",
"      Longstaffe S, Moffatt ME, Whalen JC. Behavioral and self-concept changes after six months of enuresis treatment: a randomized, controlled trial. Pediatrics 2000; 105:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/14\">",
"      Robson WL. Clinical practice. Evaluation and management of enuresis. N Engl J Med 2009; 360:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/15\">",
"      H&auml;ggl&ouml;f B, Andr&eacute;n O, Bergstr&ouml;m E, et al. Self-esteem in children with nocturnal enuresis and urinary incontinence: improvement of self-esteem after treatment. Eur Urol 1998; 33 Suppl 3:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/16\">",
"      van Londen A, van Londen-Barentsen MW, van Son MJ, Mulder GA. Arousal training for children suffering from nocturnal enuresis: a 2 1/2 year follow-up. Behav Res Ther 1993; 31:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/17\">",
"      Glazener CM, Evans JH. Simple behavioural and physical interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2004; :CD003637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/18\">",
"      Marshall S, Marshall HH, Lyon RP. Enuresis: an analysis of various therapeutic approaches. Pediatrics 1973; 52:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/19\">",
"      Schmitt BD. Nocturnal enuresis: an update on treatment. Pediatr Clin North Am 1982; 29:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/20\">",
"      Rushton HG. Nocturnal enuresis: epidemiology, evaluation, and currently available treatment options. J Pediatr 1989; 114:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/21\">",
"      Glazener CM, Evans JH, Peto RE. Alarm interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2005; :CD002911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/22\">",
"      Glazener CM, Evans JH. Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev 2002; :CD002112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/23\">",
"      Wille S. Comparison of desmopressin and enuresis alarm for nocturnal enuresis. Arch Dis Child 1986; 61:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/24\">",
"      Kwak KW, Lee YS, Park KH, Baek M. Efficacy of desmopressin and enuresis alarm as first and second line treatment for primary monosymptomatic nocturnal enuresis: prospective randomized crossover study. J Urol 2010; 184:2521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/25\">",
"      Monda JM, Husmann DA. Primary nocturnal enuresis: a comparison among observation, imipramine, desmopressin acetate and bed-wetting alarm systems. J Urol 1995; 154:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/26\">",
"      Harari MD, Moulden A. Nocturnal enuresis: what is happening? J Paediatr Child Health 2000; 36:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/27\">",
"      Hanks JW, Venters WJ. Nickel allergy from a bed-wetting alarm confused with herpes genitalis and child abuse. Pediatrics 1992; 90:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/28\">",
"      Berg I, Forsythe I, McGuire R. Response of bedwetting to the enuresis alarm. Influence of psychiatric disturbance and maximum functional bladder capacity. Arch Dis Child 1982; 57:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/29\">",
"      Rushton HG, Belman AB, Zaontz MR, et al. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis. J Urol 1996; 156:651.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Food and Drug Administration, 2007 Safety Alerts for Human Medical Products: Desmopressin Acetate (marketed as DDAVP Nasal Spray, DDAVP Rhinal Tube, DDAVP, DDVP, Minirin, and Stimate Nasal Spray). file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152113.htm (Accessed on August 26, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/31\">",
"      Bamford MF, Cruickshank G. Dangers of intranasal desmopressin for nocturnal enuresis. J R Coll Gen Pract 1989; 39:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/32\">",
"      Schwab M, Wenzel D, Ruder H. Hyponatraemia and cerebral convulsion due to short term DDAVP therapy for control of enuresis nocturna. Eur J Pediatr 1996; 155:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/33\">",
"      Bernstein SA, Williford SL. Intranasal desmopressin-associated hyponatremia: a case report and literature review. J Fam Pract 1997; 44:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/34\">",
"      Yeung CK, Chiu HN, Sit FK. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. J Urol 1999; 162:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/35\">",
"      Alloussi SH, M&uuml;rtz G, Lang C, et al. Desmopressin treatment regimens in monosymptomatic and nonmonosymptomatic enuresis: A review from a clinical perspective. J Pediatr Urol 2011; 7:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/36\">",
"      Hodges SJ, Anthony EY. Occult megarectum--a commonly unrecognized cause of enuresis. Urology 2012; 79:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/37\">",
"      O'Regan S, Yazbeck S, Hamberger B, Schick E. Constipation a commonly unrecognized cause of enuresis. Am J Dis Child 1986; 140:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/38\">",
"      Kwak KW, Park KH, Baek M. The efficacy of enuresis alarm treatment in pharmacotherapy-resistant nocturnal enuresis. Urology 2011; 77:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/39\">",
"      Glazener CM, Evans JH, Peto RE. Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev 2003; :CD002117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/40\">",
"      Gepertz S, Nev&eacute;us T. Imipramine for therapy resistant enuresis: a retrospective evaluation. J Urol 2004; 171:2607.",
"     </a>",
"    </li>",
"    <li>",
"     Martin A, Scahill L, Charney DS, Leckman JF. Pediatric Psychopharmacology: Principles and Practice, Martin A (Ed), Oxford University Press, New York 2003. p.288.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/42\">",
"      van Dommelen P, Kamphuis M, van Leerdam FJ, et al. The short- and long-term effects of simple behavioral interventions for nocturnal enuresis in young children: a randomized controlled trial. J Pediatr 2009; 154:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/43\">",
"      Jackson EC. Nocturnal enuresis: giving the child a \"lift\". J Pediatr 2009; 154:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/44\">",
"      DeFoor WR Jr, Tobias N. Simple behavioral modification may be effective first-line treatment in resolution of nocturnal enuresis. J Pediatr 2009; 155:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/45\">",
"      El-Anany FG, Maghraby HA, Shaker SE, Abdel-Moneim AM. Primary nocturnal enuresis: a new approach to conditioning treatment. Urology 1999; 53:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/46\">",
"      Van Hoeck KJ, Bael A, Van Dessel E, et al. Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children. J Urol 2007; 178:2132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/47\">",
"      Van Hoeck KJ, Bael A, Lax H, et al. Improving the cure rate of alarm treatment for monosymptomatic nocturnal enuresis by increasing bladder capacity--a randomized controlled trial in children. J Urol 2008; 179:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/48\">",
"      Persson-J&uuml;nemann C, Seemann O, K&ouml;hrmann KU, et al. Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis. Eur Urol 1993; 24:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/49\">",
"      Lovering JS, Tallett SE, McKendry JB. Oxybutynin efficacy in the treatment of primary enuresis. Pediatrics 1988; 82:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/50\">",
"      Austin PF, Ferguson G, Yan Y, et al. Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial. Pediatrics 2008; 122:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/51\">",
"      Cendron M, Klauber G. Combination therapy in the treatment of persistent nocturnal enuresis. Br J Urol 1998; 81 Suppl 3:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/52\">",
"      Nev&eacute;us T. Oxybutynin, desmopressin and enuresis. J Urol 2001; 166:2459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/53\">",
"      Nev&eacute;us T, L&auml;ckgren G, Tuvemo T, et al. Desmopressin resistant enuresis: pathogenetic and therapeutic considerations. J Urol 1999; 162:2136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/54\">",
"      Radvanska E, Kov&aacute;cs L, Rittig S. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis. J Urol 2006; 176:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/55\">",
"      Deshpande AV, Caldwell PH, Sureshkumar P. Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics). Cochrane Database Syst Rev 2012; 12:CD002238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/0/7178/abstract/56\">",
"      Huang T, Shu X, Huang YS, Cheuk DK. Complementary and miscellaneous interventions for nocturnal enuresis in children. Cochrane Database Syst Rev 2011; :CD005230.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2863 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-8C269A7C77-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7178=[""].join("\n");
var outline_f7_0_7178=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282090817\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282090869\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110105409\">",
"      PRETREATMENT EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H602906566\">",
"      MANAGEMENT APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H602908273\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H602911006\">",
"      - Goals of treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H602908662\">",
"      - General principles",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H602908167\">",
"      - When to initiate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H60381896\">",
"      - Indications for referral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H602906573\">",
"      Initial management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H602906787\">",
"      - Education and advice",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H602907926\">",
"      - Motivational therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H602906580\">",
"      Addition of active therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H602907166\">",
"      - Enuresis alarms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H94390359\">",
"      Indications and contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H94390366\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H94390373\">",
"      Instructions and adverse effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H94390380\">",
"      Monitoring response",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H602907610\">",
"      - Desmopressin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H94390395\">",
"      Indications/contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H94390402\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H94390409\">",
"      Administration and adverse effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H94390416\">",
"      Assessing response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H60385546\">",
"      Treatment of relapse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H602906587\">",
"      Refractory enuresis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Tricyclic antidepressants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H602906192\">",
"      OTHER INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H602906273\">",
"      Waking the child to urinate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H602906280\">",
"      - Alarm clocks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H602906396\">",
"      Bladder training",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Anticholinergic drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Complementary and alternative therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6534487\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2863\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2863|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/7/40061\" title=\"figure 1\">",
"      Monosymptomatic enuresis epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/52/39747\" title=\"figure 2\">",
"      Enuresis alarm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2863|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/26/41388\" title=\"table 1\">",
"      Enuresis alarms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/23/15736?source=related_link\">",
"      Effect of antidepressants on suicide risk in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=related_link\">",
"      Etiology and clinical features of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/21/40281?source=related_link\">",
"      Etiology and evaluation of nocturnal enuresis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/50/25384?source=related_link\">",
"      Evaluation and diagnosis of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=related_link\">",
"      Evaluation of suspected obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/20/6470?source=related_link\">",
"      Maintenance fluid therapy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41785?source=related_link\">",
"      Management of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/9/7315?source=related_link\">",
"      Patient information: Bedwetting in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/39/37489?source=related_link\">",
"      Patient information: Bedwetting in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/41/2710?source=related_link\">",
"      Prevention and treatment of acute constipation in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/51/28473?source=related_link\">",
"      Sleepwalking and other parasomnias in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/28/36298?source=related_link\">",
"      Treatment of chronic functional constipation and fecal incontinence in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36231?source=related_link\">",
"      Tricyclic antidepressant poisoning",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_0_7179="Cullens definition IEI";
var content_f7_0_7179=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F60215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F60215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cullen's definition of idiopathic environmental intolerance",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. A disorder acquired after a documented environmental exposure, insult, or illness.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Symptoms involving more than one organ system.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Symptoms that recur and abate in response to predictable stimuli.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Symptoms elicited by exposures to chemical of diverse structural class and toxicologic modes of action.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Symptoms that are elicited by exposures that are demonstrable.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6. Exposures that elicit symptoms are generally lower than 1 percent of established threshold limit values.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7. No single widely available test of organ system function can explain symptoms.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7179=[""].join("\n");
var outline_f7_0_7179=null;
var title_f7_0_7180="Topics in a birth plan";
var content_f7_0_7180=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F79039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F79039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Topics commonly discussed in birth plans",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Comfort measures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mobility during labor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eating and drinking during labor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Massage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acupressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Birth balls",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Music",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positioning for pushing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pharmacological pain relief",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Opiates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neuraxial analgesia and anesthesia (eg, epidural)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Support",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Who will be present during labor and delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use of professional labor support",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Children at birth and visiting postpartum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Attendance at childbirth education classes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Medical procedures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Types of electronic fetal monitoring and contraction monitoring",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use of intravenous fluids and medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Artificial rupture of membranes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oxytocin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Newborn",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mother and baby together for at least one hour after birth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Delay in administering vitamin K and eye medication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breast-feeding within the first hour",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rooming-in with no separation of mother and baby",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No water or formula for a breast-fed baby",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7180=[""].join("\n");
var outline_f7_0_7180=null;
var title_f7_0_7181="Causes of pericardial disease";
var content_f7_0_7181=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of pericardial disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Idiopathic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        In most case series, the majority of patients are not found to have an identifiable cause of pericardial disease. Frequently such cases are presumed to have a viral or autoimmune etiology.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Viral - Coxsackievirus, echovirus, adenovirus, EBV, CMV, influenza, varicella, rubella, HIV, hepatitis B, mumps, parvovirus B19, vaccina (smallpox vaccination)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bacterial - Staphylococcus, Streptococcus, pneumococcus, Haemophilus, Neisseria (gonorrhoeae or meningitidis), Chlamydia (psittaci or trachomatis), Legionella, tuberculosis, Salmonella, Lyme disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mycoplasma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fungal - Histoplasmosis, aspergillosis, blastomycosis, coccidiodomycosis, actinomycosis, nocardia, candida",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Parasitic - Echinococcus, amebiasis, toxoplasmosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Infective endocarditis with valve ring abscess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Radiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Neoplasm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Metastatic - Lung or breast cancer, Hodgkin's disease, leukemia, melanoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Primary - Rhabdomyosarcoma, teratoma, fibroma, lipoma, leiomyoma, angioma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Paraneoplastic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cardiac",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Early infarction pericarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Late postcardiac injury syndrome (Dressler's syndrome), also seen in other settings (eg, post-myocardial infarction and post-cardiac surgery)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myocarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dissecting aortic aneurysm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Blunt",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Penetrating",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Iatrogenic - Catheter and pacemaker perforations, cardiopulmonary resuscitation, post-thoracic surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Autoimmune",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rheumatic diseases - Including lupus, rheumatoid arthritis, vasculitis, scleroderma, mixed connective disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Other - Granulomatosis with polyangiitis (Wegener's), polyarteritis nodosa, sarcoidosis, inflammatory bowel disease (Crohn's, ulcerative colitis), Whipple's, giant cell arteritis, Behcet's disease, rheumatic fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Procainamide, isoniazid, or hydralazine as part of drug-induced lupus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Other - Cromolyn sodium, dantrolene, methysergide, anticoagulants, thrombolytics, phenytoin, penicillin, phenylbutazone, doxorubicin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Metabolic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypothyroidism - Primarily pericardial effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Uremia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ovarian hyperstimulation syndrome",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Shabetai R. Diseases of the pericardium. In: Hurst's The Heart, 8th ed, Schlant RC, Alexander RW, et al (Eds).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7181=[""].join("\n");
var outline_f7_0_7181=null;
var title_f7_0_7182="Prognosis of MI in relation to ST changes at 90 minutes";
var content_f7_0_7182=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 516px\">",
"   <div class=\"ttl\">",
"    Prognosis of myocardial infarction in relation to ST changes at 90 minutes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 496px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    All ST changes measured in lead with maximum change at baseline. Persistence of bundle-branch block is prognostic indication for worst outcome except when there is &lt;2 mm change at 90 minutes with an inferior infarction, when it indicates medium prognosis.",
"    <div class=\"footnotes\">",
"     * Baseline ST elevation &gt;4.5 mm.",
"     <br>",
"      &bull; Baseline ST elevation &le;4.5 mm.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Varma C, Brecker S. Lancet 2001; 358:1473, based on data from Schroder K, Wegscheider K, Zeymer U, et al. Lancet 2001; 358:1479. Copyright &copy; 2001, The Lancet Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7182=[""].join("\n");
var outline_f7_0_7182=null;
var title_f7_0_7183="Burkhalter splint for metacarpal fractures";
var content_f7_0_7183=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F77846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F77846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Burkhalter-type splint for metacarpal fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plaster splint applied with 30 degrees extension at wrist, 90 degree flexion of metacarpophalangeal (MCP) joints. On the volar aspect the splint material extends to the MCP joint; dorsally the material extends to PIP to block extension.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_0_7183=[""].join("\n");
var outline_f7_0_7183=null;
